HYDROXYPHENONE DERIVATIVE

AREA OF INVENTION

[0001] The present invention belongs to the area of antimicrobial agents for personal care, detergent and nutrition products and refers to new antimicrobial agents and their use in var ious areas of consumer products.

BACKGROUND OF THE INVENTION

[0002] In the cosmetics and pharmaceutical and in the foodstuffs industry there is a constant need for agents having antimicrobial properties, in particular for the preservation of products which are otherwise perishable (such as e.g. cosmetics, pharmaceutical products or food stuffs), but also for direct cosmetic or therapeutic treatment of microorganisms which can have an adverse influence on the human or animal body. Reference may be made by way of example to microorganisms which can cause body odour, acne, mycoses or the like.

[0003] In the technical fields referred to a large number of antimicrobial active compounds are indeed already employed, but alternatives nevertheless continue to be sought, in order to be able to perform targeted specific treatments and/or reduce side effects. In this context, however, in the search for alternative agents having an antimicrobial and in particular pre serving action it is to be noted that the substances used in the cosmetics, pharmaceutical and/or foodstuffs field must be

• toxicologically acceptable

• readily tolerated by the skin

• stable (in particular in the conventional cosmetic and/or pharmaceutical formulations)

• largely and preferably completely odourless

• inexpensive to prepare (i.e. employing standard processes and/or starting from standard precursors)

• easy to formulate (i.e. preferably liquid) and should not be detrimental to the final prod uct.

[0004] Furthermore, they should have antimicrobial activity characteristics, which fulfill the diverse criteria. They should

• provide a broad-spectrum anti-microbial activity against gram positive and gram negative bacteria, yeast and mould

• show a particularly strong activity against the mould A. brasiliensis be active in different cosmetic formulations at different pH values.

RELATED PRIOR ART

[0005] From the state of the art numerous publications are known dealing with various types of products that are active against micro-organisms. For example, Schenk et al. evaluated dif ferent fungicides for preservation of moist alfalfa hay (Laboratory evaluation of fungicides for the preservation of moist hay). 4-hydroxyacetophenone was among the compounds tested, but was found to not prevent mold growth and therefore not suitable for hay preservation. Applications in cosmetic formulations are not disclosed (Agronomy Journal, 47, 64-69, 1955).

[0006] Zauner et al. published impurities of beet molasses that inhibited the respiration and fermentation of the yeast Saccharomyces cerevisiae (Inhibitory activity of impurities of beet molasses and plant protectants on yeast (Saccharomyces cerevisiae) respiration and fermen tation.) No other microorganisms than S. cerevisiae were investigated, particularly, not molds or bacteria. No reference to potential use of the inhibitory substances in the field of cosmetics is given (Brantweinwirtschaft, 119(9), 154-6, 158-60, 163, 1979).

[0007] Hirvi et al. investigated the composition of cranberry aroma and found 4-hydroxy- aceto-phenone as one constituent. No antimicrobial activity of cranberry aroma or any of its constituents are mentioned (Zeitschrift fiir Lebensmittel-Untersuchung und -Forschung, 172(5), 365-7, 1981).

[0008] Alvarez et al. studied the anti-inflammatory properties of different constituents of the plant Lampaya hieronymi. 4-hydroxyacetophenone was one of the active compounds reduc ing subcuteaneous inflammation when administered intraperitoneally. The agents were not applied topically and no data on antimicrobial activity are disclosed for any of the presented compounds (II Farmaco, 55, 502-5, 2000).

[0009] Schmeda-Hirschmann et al. identified constituents of Tagetes mendocina revealing an tioxidant activity in a chemical in vitro assay. Among others, 4-hydroxyacetophenone proved to be one of the active constituents. No data on antimicrobial activity and no application for cosmetics are disclosed for any of the presented compounds (Zeitschrift fiir Naturforschung, 59c, 345-353, 2004).

[0010] In this context also reference is made to DE-OS 3629056 (Celamerck) discloses the ex traction of substance mixtures, including p-hydroxyacetophenone, from the cuticula of spruce needles using apolar solvents. These substance mixtures are claimed to be effective to coun teract phytopathogenic fungi, i.e. Cladosporium cucumerinum and Rhizosphaera kalkhoffii. No other microorganisms, e.g. the non-phytopathogenic yeast C. albicans or bacteria are in cluded. Furthermore, no specific application, such as product preservation of cosmetic formu lations is mentioned. [0011] US 2008/0254130 AA (Bioderm Research) discloses a topical method of treatment of dysfunction of certain dermal enzymes and the treatment of skin condition or disorder caused by said dysfunction. No antimicrobial activity of the different acetophenone derivatives is de scribed.

[0012] JP 07 206645 A (POLA) discloses acetophenone derivatives as hair growth agents. No antimicrobial activity of the different acetophenone derivatives is described.

[0013] EP 2774481 B1 (SYMRISE) suggests antimicrobial compositions comprising (a) at least one acetophenone derivative of formula (I) in which R1 stands for hydrogen or methyl, and R2 stands for hydrogen, hydroxyl or a -OCH3 group, or a cosmetically or pharmaceutically ac ceptable salt thereof, and (b) at least one second antimicrobial agent. However, it turned out that synergistic effects between components (a) and (b) are not always significant and strongly depend on weight ratios.

PROBLEM TO BE SOLVED

[0014] The search for suitable (active) substances, which have one or more of the properties mentioned to an adequate extent is made difficult for the person skilled in the art in that there is no clear dependency between the chemical structure of a substance on the one hand and its biological activity against certain microorganisms (bacteria, yeast, fungi, small eukaryotes) on the other hand. This makes testing of substances in laboratory experiments inevitable. In addition, the antimicrobial performance in cosmetic formulation cannot be derived from standard anti-microbial screening tests, such as growth inhibition experiments as described in e.g. DIN 58940 or ISO 20776. Many antimicrobial substances characterized by low minimum inhibitory concentrations (MICs) fail to perform in more advanced and applied assays. For product preservation, the highly laborious and time-consuming "challenge test" according to ISO 11930, European Pharmacopoeia 7 - 5.1.3, or United States Pharmacopoeia 35 has to be used. Furthermore, there is no predictable connection between the chemical structure and other physico-chemical parameters relevant to the field of cosmetics, i.e. the toxicological ac ceptability, the skin tolerability, the stability, solubility and formulation properties and the smell of a substance.

[0015] Therefore, the problem underlying the present invention has been developing new antimicrobial agents that fulfils the complex profile explained above and is particularly active at low concentrations against a variety of different micro-organisms. Another object of the invention has been providing emulsions comprising such antimicrobial agents with improved stability. DESCRIPTION OF THE INVENTION

Object of the present invention is an antimicrobial mixture comprising or consisting of

(a) a first antimicrobial agent selected from the group consisting of at least one acetophe none derivative of formula (I)

in which

Ri stands for hydrogen or methyl, and

R ₂ stands for hydrogen, hydroxyl or a -OCH3 group,

or a cosmetically or pharmaceutically acceptable salt thereof, and

(b) at least one second antimicrobial agent selected from the group consisting of preserva tives selected from the group consisting of:

and their mixtures.

[0016] The invention is based on the surprising finding that compounds of formula (I) accord ing to the invention show a very good broad spectrum activity as agent to preserve various formulations against microbial spoilage. Furthermore, compounds of formula (I) synergisti- cally intensified antimicrobial effects at least against selected microorganisms, in particular against mould species of the genus Aspergillus, such as Aspergillus brasiliensis, niger, flavus, fumigatus and also other microorganisms. Moulds are known to be combated only with great difficulty, due to their high tolerance for different pH, temperature, osmotic pressure and nu- trient conditions as well as their ability to resist to and degrade different chemicals.

[0017] In particular, it has been found that the mixtures according to the invention can be used outstandingly as an antimicrobial active compound mixture, in particular for preserving otherwise perishable articles.

[0018] More particularly it was found that the synergistically active mixtures according to the invention have a good action against Staphylococcus epidermidis, Corynebacterium xerosis, Brevibacterium epidermidis, Propionibacterium acnes and against Trichophyton and Epider- mophyton species, so that they can be employed as agents for the treatment or the combating of underarm and foot odour or body odour generally, as agents for combating acne, as anti dandruff agents and for the treatment of mycoses, in particular dermatomycoses. ACETOPHENONE DERIVATIVES

[0019] Acetophenone derivatives according to the present invention represent known com pounds that can be obtained by ordinary methods of organic chemistry. It is understood that both substituents ORi and R ₂ can be located in ortho, meta or para position towards the methylketo group.

[0020] Preferably, the species are selected from the group consisting of

(la): 2-hydroxyacetophenone

(lb): 3-hydroxyacetophenone

(lc): 4-hydroxyacetophenone

or their mixtures. In as far the definition refers to cosmetically or pharmaceutically acceptable salts of said derivatives, this means that these salts can be safely used for pharmaceutical purposes. This does not mean that the present invention or any aspect thereof is restricted to the use of a compound of formula (I) or a corresponding mixture for pharmaceutical purposes. Generally, if a salt can be used for pharmaceutical purposes it can likewise be used for cos metic purposes, or in food or beverage formulations. In particular, the sodium and potassium and ammonium salts of compounds of formula (I) are considered as (pharmaceutically) ac ceptable salts. In some cases the utilization of the respective ionic compound or solvate carrier proves to be superior to the unmodified derivative. The (pharmaceutically) acceptable salts (and the corresponding solvates) of compounds of formula (I) can be prepared by standard procedures. Hereinafter, any reference to a compound of formula (I) or a corresponding mix ture as defined above is to be understood as comprising an additional reference to corre sponding (pharmaceutically) acceptable salts thereof. [0021] It is also worth to be mentioned that although persons skilled in the art have already addressed the antimicrobial properties of aromatic alcohols, such as e.g. benzyl alcohol, 2- phenylethyl alcohol, 3-Phenylpropanol, 2-phenoxyethanol, 3-phenoxypropanol, 1-phenoxy- propan-2-ol, 3-phenoxy-propane-l,2-diol, benzyloxymethanol and (benzyloxymethoxy)- methanol extensively, there has hitherto been no indication that mixtures of the acetophe none derivatives have a significantly improved antimicrobial action (at least against selected microorganisms) in the individual case. It was therefore particularly surprising that the mix tures according to the invention show a highly synergistic activity, and in the treatment moulds of the genus Aspergillus are significantly superior to

• individually dosed compounds of the formula (I) or

• individually dosed further antimicrobially active compounds not being compounds of for mula (I), in particular individually dosed diols and aromatic alcohols, such as e.g. 1,3-pro- panediol, methyl propanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, ethylhex- ylglycerin, hexoxy-propan-l,2-diol, heptoxy-propan-l,2-diol, octoxy-propan-l,2-diol, 3- benzyloxy-propan-l,2-diol, 3-phenylethyloxy-propan-l,2-diol, 3-phenylpropyloxy-propan- 1,2-diol, 3-methylbenzyloxy-propan-l,2-diol, 3-phenyl propanol, 2-phenoxyethanol and mixtures of these compounds

at the same concentration, in particular in respect of the reduction in microbial counts and the speed of the reduction in microbial count.

[0022] In a preferred embodiment the antimicrobial agent comprises or contains two or three of the compounds (la), (lb) and (lc), as for example 2-hydroxyacetophenone and 3- hydroxy- acetophenone, or 2-hydroxyacetophenone and 4-hydroxyacetophenone, or 3-hydroxyaceto- phenone and 4-hydroxyacetophenone.

[0023] The mixtures may contain components (a) and (b) in a weight ratio of about 1:99 to about 99:1, preferably about 20:80 to about 80:20 and more preferably about 40:60 to about 60:40.

SECONDARY ANTIMICROBIAL AGENTS

[0024] The preferred secondary preservatives encompass the compounds compiled in Table A. Also provided are the preferred ratios by weight (4-HAP:Active) with regard to the strongest synergy effects: Table A

Preferred secondary antimicrobial agents

[0025] Mixtures of 4-hydroxyacetophenone and one of the preferred secondary antimicrobial agents - particularly within the preferred ranges - show additional advantageous effects with regard to storage stability of emulsions at temperatures below 5 and above 25 °C, which facil itates preparation of cosmetic products comprising said mixtures. ADDITIVES TO PRESERVATION MIXTURES

[0026] In a preferred embodiment the performance of the mixtures are improved by adding certain hydroxy compounds, selected from the group consisting of 1,3-propanediol, methyl propanediol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol, ethylhexylglycerin, hexoxy-pro- pan-l,2-diol, heptoxy-propan-l,2-diol, octoxy-propan-l,2-diol, 3-benzyloxy-propan-l,2-diol, 3-phenylethyloxy-propan-l,2-diol, 3-phenylpropyloxy-propan-l,2-diol, 3-methylbenzyloxy- propan-l,2-diol, 3-phenyl propanol, 2-phenoxyethanol and their mixtures. Adding 2-phenox- yethanol is particularly preferred. The additives can be present in an amount of about 1 to 25, preferably 2 to 20 and more preferably about 5 to 10 % b.w. - calculated on the total mixtures.

PERSONAL CARE COMPOSITIONS

[0027] Another embodiment of the present invention covers a personal care or cosmetic com position comprising a working amount of at least one acetophenone derivative or its mixtures with additional preservatives and/or antimicrobial agents, which might be present in amounts of from about 0.01 to about 10, preferably about 0.05 to about 5 and more preferably about 0.1 to about 1 % b.w. - calculated on the total composition.

[0028] The personal care or cosmetic compositions may contain abrasives, anti-acne agents, agents against ageing of the skin, anti-cellulitis agents, antidandruff agents, anti-inflammatory agents, irritation-preventing agents, irritation-inhibiting agents, antioxidants, astringents, per spiration-inhibiting agents, antiseptic agents, antistatics, binders, buffers, carrier materials, chelating agents, cell stimulants, cleansing agents, care agents, depilatory agents, surface-ac tive substances, deodorizing agents, antiperspirants, softeners, emulsifiers, enzymes, essen tial oils, fibres, film-forming agents, fixatives, foam-forming agents, foam stabilizers, sub stances for preventing foaming, foam boosters, gelling agents, gel-forming agents, hair care agents, hair-setting agents, hair-straightening agents, moisture-donating agents, moisturizing substances, moisture-retaining substances, bleaching agents, strengthening agents, stain-re- moving agents, optically brightening agents, impregnating agents, dirt-repellent agents, fric tion-reducing agents, lubricants, moisturizing creams, ointments, opacifying agents, plasticiz ing agents, covering agents, polish, gloss agents, polymers, powders, proteins, re-oiling agents, abrading agents, silicones, skin-soothing agents, skin-cleansing agents, skin care agents, skin-healing agents, skin-lightening agents, skin-protecting agents, skin-softening agents, cooling agents, skin-cooling agents, warming agents, skin-warming agents, stabilizers, UV-absorbing agents, UV filters, detergents, fabric conditioning agents, suspending agents, skin-tanning agents, thickeners, vitamins, oils, waxes, fats, phospholipids, saturated fatty ac ids, mono- or polyunsaturated fatty acids, a-hydroxy acids, polyhydroxy-fatty acids, liquefiers, dyestuffs, colour-protecting agents, pigments, anticorrosives, aromas, flavouring substances, odoriferous substances, polyols, surfactants, electrolytes, organic solvents or silicone deriva tives and the like as additional auxiliaries and additives.

SURFACTANTS

[0029] Other preferred auxiliaries and additives are anionic and/or amphoteric or zwitterionic surfactants. Typical examples of anionic surfactants are soaps, alkyl benzenesulfonates, al- kanesulfonates, olefin sulfonates, alkylether sulfonates, glycerol ether sulfonates, methyl es ter sulfonates, sulfofatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerol ether su l fates, fatty acid ether sulfates, hydroxy mixed ether sulfates, monoglyceride (ether) sulfates, fatty acid amide (ether) sulfates, mono- and dialkyl sulfosuccinates, mono- and dialkyl sul- fosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and salts thereof, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, N-acylamino acids such as, for example, acyl lactylates, acyl tartrates, acyl glutamates and acyl aspartates, alkyl oligogluco- side sulfates, protein fatty acid condensates (particularly wheat-based vegetable products) and alkyl (ether) phosphates. If the anionic surfactants contain polyglycol ether chains, they may have a conventional homolog distribution although they preferably have a narrow-range homolog distribution. Typical examples of amphoteric or zwitterionic surfactants are alkylbe- taines, alkylamidobetaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines. The surfactants mentioned are all known compounds. Information on their structure and production can be found in relevant synoptic works, cf. for example J. Falbe (ed.), "Surfactants in Consumer Products", Springer Verlag, Berlin, 1987, pages 54 to 124 or J. Falbe (ed.), "Katalysatoren, Tenside und Mineraloladditive (Catalysts, Surfactants and Mineral Oil Additives)", Thieme Verlag, Stuttgart, 1978, pages 123-217. The percentage con tent of surfactants in the preparations may be from 0.1 to 10% by weight and is preferably from 0.5 to 5% by weight, based on the preparation. B. Oil bodies

[0030] Suitable oil bodies, which form constituents of the O/W emulsions, are, for example, Guerbet alcohols based on fatty alcohols having 6 to 18, preferably 8 to 10, carbon atoms, esters of linear C ₆ -C ₂₂ -fatty acids with linear or branched C ₆ -C ₂₂ -fatty alcohols or esters of branched C ₆ -C ₁₃ -carboxylic acids with linear or branched C ₆ -C ₂₂ -fatty alcohols, such as, for example, myristyl myristate, myristyl palmitate, myristyl stearate, myristyl isostearate, myri- styl oleate, myristyl behenate, myristyl erucate, cetyl myristate, cetyl palmitate, cetyl stearate, cetyl isostearate, cetyl oleate, cetyl behenate, cetyl erucate, stearyl myristate, stearyl palmi tate, stearyl stearate, stearyl isostearate, stearyl oleate, stearyl behenate, stearyl erucate, isostearyl myristate, isostearyl palmitate, isostearyl stearate, isostearyl isostearate, isostearyl oleate, isostearyl behenate, isostearyl oleate, oleyl myristate, oleyl palmitate, oleyl stearate, oleyl isostearate, oleyl oleate, oleyl behenate, oleyl erucate, behenyl myristate, behenyl pal mitate, behenyl stearate, behenyl isostearate, behenyl oleate, behenyl behenate, behenyl erucate, erucyl myristate, erucyl palmitate, erucyl stearate, erucyl isostearate, erucyl oleate, erucyl behenate and erucyl erucate. Also suitable are esters of linear C ₆ -C ₂₂ -fatty acids with branched alcohols, in particular 2-ethylhexanol, esters of C ₁₈ -C ₃₈ - alkylhydroxy carboxylic acids with linear or branched C ₆ -C ₂₂ -fatty alcohols, in particular Dioctyl Malate, esters of linear and/or branched fatty acids with polyhydric alcohols (such as, for example, propylene glycol, dimerdiol or trimertriol) and/or Guerbet alcohols, triglycerides based on C ₆ -Cio-fatty acids, liquid mono-/di-/triglyceride mixtures based on C ₆ -Cis-fatty acids, esters of C ₆ - C ₂₂ -fatty alco hols and/or Guerbet alcohols with aromatic carboxylic acids, in particular benzoic acid, esters of C ₂ - Ci ₂ -dicarboxylic acids with linear or branched alcohols having 1 to 22 carbon atoms or polyols having 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils, branched pri mary alcohols, substituted cyclohexanes, linear and branched C ₆ -C22-fatty alcohol carbonates, such as, for example, Dicaprylyl Carbonate (Cetiol ^® CC), Guerbet carbonates, based on fatty alcohols having 6 to 18, preferably 8 to 10, carbon atoms, esters of benzoic acid with linear and/or branched C6-C22-alcohols (e.g. Finsolv ^® TN), linear or branched, symmetrical or asym metrical dialkyl ethers having 6 to 22 carbon atoms per alkyl group, such as, for example, di caprylyl ether (Cetiol ^® OE), ring-opening products of epoxidized fatty acid esters with polyols, silicone oils (cyclomethicones, silicone methicone grades, etc.) and/or aliphatic or naphthenic hydrocarbons, such as, for example, squalane, squalene or dialkylcyclohexanes.

EMULSIFIERS

[0031] Other surfactants may also be added to the preparations as emulsifiers, including for example:

• products of the addition of 2 to 30 mol ethylene oxide and/or 0 to 5 mol propylene oxide onto linear Cs-22 fatty alcohols, onto C12-22 fatty acids and onto alkyl phenols containing 8 to 15 carbon atoms in the alkyl group;

• C12/18 fatty acid monoesters and diesters of addition products of 1 to 30 mol ethylene oxide onto glycerol;

• glycerol mono- and diesters and sorbitan mono- and diesters of saturated and unsatu rated fatty acids containing 6 to 22 carbon atoms and ethylene oxide addition products thereof;

• addition products of 15 to 60 mol ethylene oxide onto castor oil and/or hydrogenated castor oil;

• polyol esters and, in particular, polyglycerol esters such as, for example, polyglycerol polyricinoleate, polyglycerol poly-12-hydroxystearate or polyglycerol dimerate isos tearate. Mixtures of compounds from several of these classes are also suitable;

• addition products of 2 to 15 mol ethylene oxide onto castor oil and/or hydrogenated castor oil;

• partial esters based on linear, branched, unsaturated or saturated C6/22 fatty acids, ric- inoleic acid and 12-hydroxystearic acid and glycerol, polyglycerol, pentaerythritol, di- pentaerythritol, sugar alcohols (for example sorbitol), alkyl glucosides (for example me thyl glucoside, butyl glucoside, lauryl glucoside) and polyglucosides (for example cellu lose);

• mono-, di and trialkyl phosphates and mono-, di- and/or tri-PEG-alkyl phosphates and salts thereof;

• wool wax alcohols; • polysiloxane/polyalkyl polyether copolymers and corresponding derivatives;

• mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol and/or mixed esters of C ₆ -22 fatty acids, methyl glucose and polyols, preferably glycerol or polyglycerol,

• polyalkylene glycols and

• glycerol carbonate.

[0032] The addition products of ethylene oxide and/or propylene oxide onto fatty alcohols, fatty acids, alkylphenols, glycerol mono- and diesters and sorbitan mono- and diesters of fatty acids or onto castor oil are known commercially available products. They are homologue mix tures of which the average degree of alkoxylation corresponds to the ratio between the quan tities of ethylene oxide and/or propylene oxide and substrate with which the addition reaction is carried out. C12/18 fatty acid monoesters and diesters of addition products of ethylene oxide onto glycerol are known as lipid layer enhancers for cosmetic formulations. The preferred emulsifiers are described in more detail as follows:

[0033] Partial glycerides. Typical examples of suitable partial glycerides are hydroxystearic acid monoglyceride, hydroxystearic acid diglyceride, isostearic acid monoglyceride, isostearic acid diglyceride, oleic acid monoglyceride, oleic acid diglyceride, ricinoleic acid monoglyceride, ricinoleic acid diglyceride, linoleic acid monoglyceride, linoleic acid diglyceride, linolenic acid monoglyceride, linolenic acid diglyceride, erucic acid monoglyceride, erucic acid diglyceride, tartaric acid monoglyceride, tartaric acid diglyceride, citric acid monoglyceride, citric acid di glyceride, malic acid monoglyceride, malic acid diglyceride and technical mixtures thereof which may still contain small quantities of triglyceride from the production process. Addition products of 1 to 30 and preferably 5 to 10 mol ethylene oxide onto the partial glycerides men tioned are also suitable.

[0034] Sorbitan esters. Suitable sorbitan esters are sorbitan monoisostearate, sorbitan ses- quiisostearate, sorbitan diisostearate, sorbitan triisostearate, sorbitan monooleate, sorbitan sesquioleate, sorbitan dioleate, sorbitan trioleate, sorbitan monoerucate, sorbitan sesquieru- cate, sorbitan dierucate, sorbitan trierucate, sorbitan monoricinoleate, sorbitan sesquiricino- leate, sorbitan diricinoleate, sorbitan triricinoleate, sorbitan monohydroxystearate, sorbitan sesquihydroxystearate, sorbitan dihydroxystearate, sorbitan trihydroxystearate, sorbitan monotartrate, sorbitan sesquitartrate, sorbitan ditartrate, sorbitan tritartrate, sorbitan monocitrate, sorbitan sesquicitrate, sorbitan dicitrate, sorbitan tricitrate, sorbitan monoma- leate, sorbitan sesquimaleate, sorbitan dimaleate, sorbitan trimaleate and technical mixtures thereof. Addition products of 1 to 30 and preferably 5 to 10 mol ethylene oxide onto the sorbitan esters mentioned are also suitable.

[0035] Polyglycerol esters. Typical examples of suitable polyglycerol esters are Polyglyceryl-2 Dipolyhydroxystearate (Dehymuls ^® PGPH), Polyglycerin-3-Diisostearate (Lameform ^® TGI), Pol- yglyceryl-4 Isostearate (Isolan ^® Gl 34), Polyglyceryl-3 Oleate, Diisostearoyl Polyglyceryl-3 Diisostearate (Isolan ^® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care ^® 450), Poly- glyceryl-3 Beeswax (Cera Beilina ^® ), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010/90), Polyglyceryl-3 Cetyl Ether (Chimexane ^® NL), Polyglyceryl-3 Distearate (Cremophor ^® GS 32) and Polyglyceryl Polyricinoleate (Admul ^® WOL 1403), Polyglyceryl Dimerate Isostearate and mix tures thereof. Examples of other suitable polyolesters are the mono-, di- and triesters of tri- methylol propane or pentaerythritol with lauric acid, cocofatty acid, tallow fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like optionally reacted with 1 to 30 mol ethylene oxide.

[0036] Anionic emulsifiers. Typical anionic emulsifiers are aliphatic C12-22 fatty acids, such as palmitic acid, stearic acid or behenic acid for example, and C12-22 dicarboxylic acids, such as azelaic acid or sebacic acid for example.

[0037] Amphoteric emulsifiers. Other suitable emulsifiers are amphboteric or zwitterionic surfactants. Zwitterionic surfactants are surface-active compounds which contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines, such as the N-alkyl-N,N-dimethyl ammonium glycinates, for example cocoalkyl dimethyl ammonium glycinate, N-acylaminopropyl-N,N-dimethyl ammonium glycinates, for example cocoacyla- minopropyl dimethyl ammonium glycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethyl im idazolines containing 8 to 18 carbon atoms in the alkyl or acyl group and cocoacylaminoethyl hydroxyethyl carboxymethyl glycinate. The fatty acid amide derivative known under the CTFA name of Cocamidopropyl Betaine is particularly preferred. Ampholytic surfactants are also suitable emulsifiers. Ampholytic surfactants are surface -active compounds which, in addition to a Cs/i8 alkyl or acyl group, contain at least one free amino group and at least one -COOH- or -SO3H- group in the molecule and which are capable of forming inner salts. Examples of suitable ampholytic surfactants are N-alkyl glycines, N-alkyl propionic acids, N-alkylaminobu- tyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropyl glycines, N-al- kyl taurines, N-alkyl sarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids con taining around 8 to 18 carbon atoms in the alkyl group. Particularly preferred ampholytic sur factants are N-cocoalkylaminopropionate, cocoacylaminoethyl aminopropionate and C12/18 acyl sarcosine.

SUPERFATTING AGENTS AND CONSISTENCY FACTORS

[0038] Superfatting agents may be selected from such substances as, for example, lanolin and lecithin and also polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides, the fatty acid alkanolamides also serving as foam stabilizers.

[0039] The consistency factors mainly used are fatty alcohols or hydroxyfatty alcohols con taining 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids. A combination of these substances with alkyl oligoglucosides and/or fatty acid N-methyl glucamides of the same chain length and/or polyglycerol poly-12-hy- droxystea rates is preferably used.

THICKENING AGENTS AND RHEOLOGY ADDITIVES

[0040] Suitable thickeners are polymeric thickeners, such as Aerosil ^® types (hydrophilic sili cas), polysaccharides, more especially xanthan gum, guar-guar, agar-agar, alginates and tylo ses, carboxymethyl cellulose and hydroxyethyl cellulose, also relatively high molecular weight polyethylene glycol monoesters and diesters of fatty acids, polyacrylates (for example Carbo- pols ^® [Goodrich] or Synthalens ^® [Sigma]), polyacrylamides, polyvinyl alcohol and polyvinyl pyrrolidone, surfactants such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols, for example pentaerythritol or trimethylol propane, narrow-range fatty al cohol ethoxylates and electrolytes, such as sodium chloride and ammonium chloride.

POLYMERS

[0041] Suitable cationic polymers are, for example, cationic cellulose derivatives such as, for example, the quaternized hydroxyethyl cellulose obtainable from Amerchol under the name of Polymer JR 400 ^® , cationic starch, copolymers of diallyl ammonium salts and acrylamides, quaternized vinyl pyrrolidone/vinyl imidazole polymers such as, for example, Luviquat ^® (BASF), condensation products of polyglycols and amines, quaternized collagen polypeptides such as, for example, Lauryldimonium Hydroxypropyl Hydrolyzed Collagen (Lamequat ^® L, Grunau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers such as, for example, amodimethicone, copolymers of adipic acid and dimethylaminohydroxypro- pyl diethylenetriamine (Carta retine ^® , Sandoz), copolymers of acrylic acid with dimethyl diallyl ammonium chloride (Merquat ^® 550, Chemviron), polyaminopolyamides and crosslinked wa ter-soluble polymers thereof, cationic chitin derivatives such as, for example, quaternized chi- tosan, optionally in microcrystalline distribution, condensation products of dihaloalkyls, for example dibromobutane, with bis-dialkylamines, for example bis-dimethylamino-1, 3-pro- pane, cationic guar gum such as, for example, Jaguar ^® CBS, Jaguar ^® C-17, Jaguar ^® C-16 of Cela- nese, quaternized ammonium salt polymers such as, for example, Mirapol ^® A-15, Mirapol ^® AD- 1, Mirapol ^® AZ-1 of Miranol and the various polyquaternium types (for example 6, 7, 32 or 37) which can be found in the market under the tradenames Rheocare ^® CC or Ultragel ^® 300.

[0042] Suitable anionic, zwitterionic, amphoteric and nonionic polymers are, for example, vi nyl acetate/crotonic acid copolymers, vinyl pyrrolidone/vinyl acrylate copolymers, vinyl ace tate/butyl maleate/isobornyl acrylate copolymers, methyl vinylether/maleic anhydride copol ymers and esters thereof, uncrosslinked and polyol-crosslinked polyacrylic acids, acrylamido- propyl trimethylammonium chloride/acrylate copolymers, octylacrylamide/methyl methacry- late/tert.-butylaminoethyl methacrylate/2-hydroxypropyl methacrylate copolymers, polyvi- nyl pyrrolidone, vinyl pyrrolidone/vinyl acetate copolymers, vinyl pyrrolidone/dimethylami- noethyl methacrylate/vinyl caprolactam terpolymers and optionally derivatized cel lulose ethers and silicones.

PEARLISING WAXES

[0043] Suitable pearlising waxes are, for example, alkylene glycol esters, especially ethylene glycol distearate; fatty acid alkanolamides, especially cocofatty acid diethanolamide; partial glycerides, especially stearic acid monoglyceride; esters of polybasic, optionally hydroxysub- stituted carboxylic acids with fatty alcohols containing 6 to 22 carbon atoms, especially long- chain esters of tartaric acid; fatty compounds, such as for example fatty alcohols, fatty ke tones, fatty aldehydes, fatty ethers and fatty carbonates which contain in all at least 24 carbon atoms, especially laurone and distearylether; fatty acids, such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides containing 12 to 22 carbon at oms with fatty alcohols containing 12 to 22 carbon atoms and/or polyols containing 2 to 15 carbon atoms and 2 to 10 hydroxyl groups and mixtures thereof.

SILICONES

[0044] Suitable silicone compounds are, for example, dimethyl polysiloxanes, methylphenyl polysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine-, glycoside- and/or alkyl-modified silicone compounds which may be both liquid and resin-like at room temperature. Other suitable silicone compounds are simethicones which are mix tures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates. A detailed overview of suitable volatile silicones can be found in Todd et al. in Cosm. Toil. 91, 27 (1976).

[0045] WAXES AND STABILISERS

[0046] Besides natural oils used, waxes may also be present in the preparations, more espe cially natural waxes such as, for example, candelilla wax, carnauba wax, Japan wax, espar- tograss wax, cork wax, guaruma wax, rice oil wax, sugar cane wax, ouricury wax, montan wax, beeswax, shellac wax, spermaceti, lanolin (wool wax), uropygial fat, ceresine, ozocerite (earth wax), petrolatum, paraffin waxes and microwaxes; chemically modified waxes (hard waxes) such as, for example, montan ester waxes, sasol waxes, hydrogenated jojoba waxes and syn thetic waxes such as, for example, polyalkylene waxes and polyethylene glycol waxes.

[0047] Metal salts of fatty acids such as, for example, magnesium, aluminium and/or zinc stea rate or ricinoleate may be used as stabilizers.

PRIMARY SUN PROTECTION FACTORS

[0048] Primary sun protection factors in the context of the invention are, for example, organic substances (light filters) which are liquid or crystalline at room temperature and which are capable of absorbing ultraviolet radiation and of releasing the energy absorbed in the form of longer-wave radiation, for example heat.

[0049] The formulations according to the invention advantageously contain at least one UV- A filter and/or at least one UV-B filter and/or a broadband filter and/or at least one inorganic pigment. Formulations according to the invention preferably contain at least one UV-B filter or a broadband filter, more particularly preferably at least one UV-A filter and at least one UV- B filter.

[0050] Preferred cosmetic compositions, preferably topical formulations according to the pre sent invention comprise one, two, three or more sun protection factors selected from the group consistiung of 4-aminobenzoic acid and derivatives, salicylic acid derivatives, benzo- phenone derivatives, dibenzoylmethane derivatives, diphenyl acrylates, 3-imidazol-4-yl acrylic acid and esters thereof, benzofuran derivatives, benzylidene malonate derivatives, polymeric UV absorbers containing one or more organosilicon radicals, cinnamic acid derivatives, cam phor derivatives, trianilino-s-triazine derivatives, 2-hydroxyphenylbenzotriazole derivatives, phenylbenzimidazole sulfonic acid derivatives and salts thereof, anthranilic acid menthyl es ters, benzotriazole derivativesand indole derivatives.

[0051] In addition, it is advantageous to combine compounds of formula (I) with active ingre dients which penetrate into the skin and protect the skin cells from inside against sunlight- induced damage and reduce the level of cutaneous matrix metalloproteases. Preferred re spective ingredients, so called arylhydrocarbon receptor antagonists, are described in WO 2007/128723, incorporated herein by reference. Preferred is 2-benzylidene-5,6-dimethoxy- 3,3-dimethylindan-l-one.

[0052] The UV filters cited below which can be used within the context of the present invention are preferred but naturally are not limiting.

[0053] UV filters which are preferably used are selected from the group consisting of

p-aminobenzoic acid

p-aminobenzoic acid ethyl ester (25 mol) ethoxylated (INCI name: PEG-25 PABA) p-dimethylaminobenzoic acid-2-ethylhexyl ester

p-aminobenzoic acid ethyl ester (2 mol) N-propoxylated

p-aminobenzoic acid glycerol ester

salicylic acid homomenthyl ester (homosalates) (Neo Heliopan ^® HMS)

salicylic acid-2-ethylhexyl ester (Neo Heliopan ^® OS)

triethanolamine salicylate

4-isopropyl benzyl salicylate

anthranilic acid menthyl ester (Neo Heliopan ^® MA)

diisopropyl cinnamic acid ethyl ester p-methoxycinnamic acid-2-ethylhexyl ester (Neo Heliopan ^® AV)

diisopropyl cinnamic acid methyl ester

p-methoxycinnamic acid isoamyl ester (Neo Heliopan ^® E 1000)

p-methoxycinnamic acid diethanolamine salt

p-methoxycinnamic acid isopropyl ester

2-phenylbenzimidazole sulfonic acid and salts (Neo Heliopan ^® Hydro)

3-(4'-trimethylammonium) benzylidene bornan-2-one methyl sulfate

beta-imidazole-4(5)-acrylic acid (urocanic acid)

3-(4'-sulfo)benzylidene bornan-2-one and salts

3-(4'-methyl benzylidene)-D,L-camphor (Neo Heliopan ^® MBC)

3-benzylidene-D,L-camphor

N-[(2 and 4)-[2-(oxoborn-3-ylidene) methyl]benzyl] acrylamide polymer

4,4'-[(6-[4-(l,l-dimethyl)aminocarbonyl) phenylamino]-l,3,5-triazine-2,4-diyl)diimino]- bis-(benzoic acid-2-ethylhexyl ester) (Uvasorb ^® HEB)

benzylidene malonate polysiloxane (Parsol ^® SLX)

glyceryl ethylhexanoate dimethoxycinnamate

dipropylene glycol salicylate

tris(2-ethylhexyl)-4,4 ^, ,4"-(l,3,5-triazine-2,4,6-triyltriimino)tribenzoate (= 2,4,6- trianilino-(p-carbo-2'-ethylhexyl-l ^, -oxy)-l,3,5-triazine) (Uvinul ^® T150)

[0054] Broadband filters which are preferably combined with one or more compounds of formula (I) in a preparation according to the present invention are selected from the group consisting of

2-ethylhexyl-2-cyano-3, 3-diphenyl acrylate (Neo Heliopan ^® 303)

ethyl-2-cyano-3,3'-diphenyl acrylate

2-hydroxy-4-methoxybenzophenone (Neo Heliopan ^® BB)

2-hydroxy-4-methoxybenzophenone-5-sulfonic acid

dihydroxy-4-methoxybenzophenone

2,4-dihydroxybenzophenone

tetrahydroxybenzophenone

2,2'-dihydroxy-4,4'-dimethoxybenzophenone 2-hydroxy-4-n-octoxybenzophenone

2-hydroxy-4-methoxy-4'-methyl benzophenone

sodium hydroxymethoxybenzophenone sulfonate

disodium-2,2'-dihydroxy-4,4'-dimethoxy-5,5 ^, -disulfobenzophenone

phenol, 2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3(l,3,3,3-tetr amethyl-l-(trime- thylsilyl)oxy)disiloxyanyl) propyl) (Mexoryl®XL)

2,2'-methylene bis-(6-(2H-benzotriazol-2-yl)-4-l,l,3,3-tetramethylbutyl) phenol) (Tinosorb ^® M)

2.4-bis-[4-(2-ethylhexyloxy)-2-hydroxyphenyl]-l,3,5-triazine

2.4-bis-[{ (4-(2-ethylhexyloxy)-2-hydroxy} phenyl]-6-(4-methoxyphenyl)-l,3,5-triazine (Tinosorb ^® S)

2.4-bis-[{ (4-(3-sulfonato)-2-hydroxypropyloxy)-2-hydroxy} phenyl]-6-(4- methoxyphenyl)-l,3,5-triazine sodium salt

2.4-bis-[{ (3-(2-propyloxy)-2-hydroxypropyloxy)-2-hydroxy} phenyl]-6-(4- methoxyphenyl)-l,3,5-triazine

2.4-bis-[{4-(2-ethylhexyloxy)-2-hydroxy} phenyl]-6-[4-(2-methoxyethyl carbonyl) phenylamino]-l,3,5-triazine

2.4-bis-[{4-(3-(2-propyloxy)-2-hydroxypropyloxy)-2-hydroxy} phenyl]-6-[4-(2- ethylcarboxyl) phenylamino]-l,3,5-triazine

2.4-bis-[{4-(2-ethylhexyloxy)-2-hydroxy} phenyl]-6-(l-methylpyrrol-2-yl)-l,3,5-triazine

2.4-bis-[{4-tris-(trimethylsiloxysilylpropyloxy)-2-hydrox y} phenyl]-6-(4- methoxyphenyl)-l,3,5-triazine

2.4-bis-[{4-(2"-methylpropenyloxy)-2-hydroxy} phenyl]-6-(4-methoxyphenyl)-l,3,5- triazine

2.4-bis-[{4-( , , ,3',5 ^, ,5 ^, ,5'-heptamethylsiloxy-2"-methylpropyloxy)-2- hydroxy} phenyl]-6-(4-methoxyphenyl)-l,3,5-triazine

UV-A filters filters which are preferably combined with one or more compounds of formula (I) in a preparation according to the present invention are selected from the group consisting of

• 4-isopropyl dibenzoyl methane

• terephthalylidene dibornane sulfonic acid and salts (Mexoryl ^® SX)

• 4-t-butyl-4'-methoxydibenzoyl methane (avobenzone) / (Neo Heliopan ^® 357)

• phenylene bis-benzimidazyl tetrasulfonic acid disodium salt (Neo Heliopan ^® AP) • 2,2'-(l,4-phenylene)-bis-(lH-benzimidazole-4,6-disulfonic acid), monosodium salt

• 2-(4-diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester (Uvinul ^® A Plus)

• indanylidene compounds in accordance with DE 100 55 940 A1 (= WO 2002 038537 Al)

[0055] UV filters which are more preferably combined with one or more compounds of formula (I) in a preparation according to the present invention are selected from the group consisting of

p-aminobenzoic acid

3-(4'-trimethylammonium) benzylidene bornan-2-one methyl sulfate

salicylic acid homomenthyl ester (Neo Heliopan ^® HMS)

2-hydroxy-4-methoxybenzophenone (Neo Heliopan ^® BB)

2-phenylbenzimidazole sulfonic acid (Neo Heliopan ^® Hydro)

terephthalylidene dibornane sulfonic acid and salts (Mexoryl ^® SX)

4-tert-butyl-4'-methoxydibenzoyl methane (Neo Heliopan ^® 357)

3-(4'-sulfo)benzylidene bornan-2-one and salts

2-ethylhexyl-2-cyano-3, 3-diphenyl acrylate (Neo Heliopan ^® 303)

N-[(2 and 4)-[2-(oxoborn-3-ylidene) methyl]benzyl] acrylamide polymer

p-methoxycinnamic acid-2-ethylhexyl ester (Neo Heliopan ^® AV)

p-aminobenzoic acid ethyl ester (25 mol) ethoxylated (INCI name: PEG-25 PABA) p-methoxycinnamic acid isoamyl ester (Neo Heliopan ^® E1000)

2,4,6-trianilino-(p-carbo-2'-ethylhexyl-l'-oxy)-l,3,5-triazi ne (Uvinul ^® T150)

phenol, 2-(2H-benzotriazol-2-yl)-4-methyl-6-(2-methyl-3(l,3,3,3-tetr amethyl-l-(trime- thylsilyl)oxy)disiloxyanyl) propyl) (Mexoryl ^® XL)

4,4'-[(6-[4-(l,l-dimethyl)aminocarbonyl) phenylamino]-l,3,5-triazine-2,4-diyl)diimino]- bis-(benzoic acid-2-ethylhexyl ester) (Uvasorb HEB)

3-(4'-methyl benzylidene)-D,L-camphor (Neo Heliopan ^® MBC)

3-benzylidene camphor

salicylic acid-2-ethylhexyl ester (Neo Heliopan ^® OS)

4-dimethylaminobenzoic acid-2-ethylhexyl ester (Padimate O)

hydroxy-4-methoxybenzophenone-5-sulfonic acid and Na salt

2,2'-methylene bis-(6-(2H-benzotriazol-2-yl)-4-l,l,3,3-tetramethylbutyl) phenol) (Tinosorb ^® M) • phenylene bis-benzimidazyl tetrasulfonic acid disodium salt (Neo Heliopan ^® AP)

• 2,4-bis-[{ (4-(2-ethylhexyloxy)-2-hydroxy} phenyl]-6-(4-methoxyphenyl)-l,3,5-triazine (Tinosorb ^® S)

• benzylidene malonate polysiloxane (Parsol ^® SLX)

• menthyl anthranilate (Neo Heliopan ^® MA)

• 2-(4-diethylamino-2-hydroxybenzoyl) benzoic acid hexyl ester (Uvinul ^® A Plus)

• indanylidene compounds in accordance with DE 100 55 940 (= WO 02/38537).

[0056] Advantageous primary and also secondary sun protection factors are mentioned in WO 2005 123101 Al. Advantageously, these preparations contain at least one UVA filter and/or at least one UVB filter and/or at least one inorganic pigment. The preparations may be present here in various forms such as are conventionally used for sun protection preparations. Thus, they may be in form of a solution, an emulsion of the water-in-oil type (W/O) or of the oil-in-water type (O/W) or a multiple emulsion, for example of the water-in-oil-in-water type (W/O/W), a gel, a hydrodispersion, a solid stick or else an aerosol.

[0057] In a further preferred embodiment a formulation according to the invention contains a total amount of sunscreen agents, i.e. in particular UV filters and/or inorganic pigments (UV filtering pigments) so that the formulation according to the invention has a light protection factor of greater than or equal to 2 (preferably greater than or equal to 5). Such formulations according to the invention are particularly suitable for protecting the skin and hair.

SECONDARY SUN PROTECTION FACTORS

[0058] Besides the groups of primary sun protection factors mentioned above, secondary sun protection factors of the antioxidant type may also be used. Secondary sun protection factors of the antioxidant type interrupt the photochemical reaction chain which is initiated when UV rays penetrate into the skin. Typical examples are amino acids (for example glycine, histidine, tyrosine, tryptophane) and derivatives thereof, imidazoles (for example urocanic acid) and derivatives thereof, peptides, such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (for example anserine), carotinoids, carotenes (for example alpha-carotene, beta-car otene, lycopene) and derivatives thereof, chlorogenic acid and derivatives thereof, liponic acid and derivatives thereof (for example dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (for example thioredoxine, glutathione, cysteine, cystine, cystamine and gly- cosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, alpha-linoleyl, cholesteryl and glyceryl esters thereof) and their salts, dilaurylthiodipropionate, distearylthi- odipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (for example butionine sul- foximines, homocysteine sulfoximine, butionine sulfones, penta-, hexa- and hepta-thionine sulfoximine) in very small compatible dosages, also (metal) chelators (for example alpha-hy- droxyfatty acids, palmitic acid, phytic acid, lactoferrine), alpha-hydroxy acids (for example cit ric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof, unsaturated fatty acids and derivatives thereof (for example linoleic acid, oleic acid), folic acid and derivatives thereof, ubiquinone and ubiquinol and de rivatives thereof, vitamin C and derivatives thereof (for example ascorbyl palmitate, Mg ascor- byl phosphate, ascorbyl acetate), tocopherols and derivatives (for example vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of benzoin resin, rutinic acid and derivatives thereof, glycosyl rutin, ferulic acid, furfurylidene glucitol, carnosine, butyl hydroxytoluene, butyl hydroxyanisole, nordihydroguaiac resin acid, nordihydroguaiaretic acid, trihydroxybutyrophenone, uric acid and derivatives thereof, mannose and derivatives thereof, superoxide dismutase, titanium dioxide (for example dispersions in ethanol), zinc and derivatives thereof (for example ZnO, ZnS0 ₄ ), selenium and derivatives thereof (for example selenium methionine), stilbenes and derivatives thereof (for example stilbene oxide, trans- stilbene oxide) and derivatives of these active substances suitable for the purposes of the in vention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids).

[0059] Advantageous inorganic secondary light protection pigments are finely dispersed metal oxides and metal salts which are also mentioned in WO 2005 123101 Al. The total quantity of inorganic pigments, in particular hydrophobic inorganic micro-pigments in the fin ished cosmetic preparation according to the present invention is advantageously from 0.1 to 30% by weight, preferably 0.5 to 10.0% by weight, in each case based on the total weight of the preparation.

[0060] Also preferred are particulate UV filters or inorganic pigments, which can optionally be hydrophobed, can be used, such as the oxides of titanium (Ti0 ₂ ), zinc (ZnO), iron (Fe ₂ 03), zirconium (Zr0 ₂ ), silicon (Si0 ₂ ), manganese (e.g. MnO), aluminium (Al ₂ 03), cerium (e.g. Ce ₂ Os) and/or mixtures thereof.

ANTI-AGEING ACTIVES

[0061] In the context of the invention, anti-ageing or biogenic agents are, for example antiox idants, matrix-metalloproteinase inhibitrors (MMPI), skin moisturizing agents, glycosamingly- can stimulkators, anti-inflammatory agents, TRPV1 antagonists and plant extracts.

[0062] Antioxidants, amino acids (preferably glycine, histidine, tyrosine, tryptophane) and derivatives thereof, imidazoles (preferably urocanic acid) and derivatives thereof, peptides, preferably D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (preferably anser ine), carnitine, creatine, matrikine peptides (preferably lysyl-threonyl-threonyl-lysyl-serine) and palmitoylated pentapeptides, carotenoids, carotenes (preferably alpha-carotene, beta- carotene, lycopene) and derivatives thereof, lipoic acid and derivatives thereof (preferably dihydrolipoic acid), aurothioglucose, propyl thiouracil and other thiols (preferably thioredox- ine, glutathione, cysteine, cystine, cystamine and glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, gamma-linoleyl, cholesteryl, glyceryl and oligoglyceryl esters thereof) and salts thereof, dilauryl thiodipropionate, distearyl thiodipropionate, thiodi- propionic acid and derivatives thereof (preferably esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (preferably buthionine sulfoximines, ho mocysteine sulfoximine, buthionine sulfones, penta-, hexa-, heptathionine sulfoximine) in very small tolerated doses (e.g. pmol to pmol/kg), also (metal) chelators (preferably alpha - hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin, alpha-hydroxy acids (preferably citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, tannins, bilirubin, biliverdin, EDTA, EGTA and derivatives thereof), unsaturated fatty acids and derivatives thereof (prefer ably gamma-linolenic acid, linoleic acid, oleic acid), folic acid and derivatives thereof, ubiqui none and derivatives thereof, ubiquinol and derivatives thereof, vitamin C and derivatives (preferably ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate, ascorbyl glucoside), tocopherols and derivatives (preferably vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of benzoic resin, rutinic acid and derivatives thereof, fla- vonoids and glycosylated precursors thereof, in particular quercetin and derivatives thereof, preferably alpha-glucosyl rutin, rosmarinic acid, carnosol, carnosolic acid, resveratrol, caffeic acid and derivatives thereof, sinapic acid and derivatives thereof, ferulic acid and derivatives thereof, curcuminoids, chlorogenic acid and derivatives thereof, retinoids, preferably retinyl palmitate, retinol or tretinoin, ursolic acid, levulinic acid, butyl hydroxytoluene, butyl hydrox- yanisole, nordihydroguaiac acid, nordihydroguaiaretic acid, trihydroxybutyrophenone, uric acid and derivatives thereof, mannose and derivatives thereof, zinc and derivatives thereof (preferably ZnO, ZnS0 ₄ ), selenium and derivatives thereof (preferably selenium methionine), superoxide dismutase, stilbenes and derivatives thereof (preferably stilbene oxide, trans-stil- bene oxide) and the derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, pep tides and lipids) of these cited active ingredients which are suitable according to the invention or extracts or fractions of plants having an antioxidant effect, preferably green tea, rooibos, honeybush, grape, rosemary, sage, melissa, thyme, lavender, olive, oats, cocoa, ginkgo, gin seng, liquorice, honeysuckle, sophora, pueraria, pinus, citrus, Phyllanthus emblica or St. John's wort, grape seeds, wheat germ, Phyllanthus emblica, coenzymes, preferably coenzyme Q.10, plastoquinone and menaquinone. Preferred antioxidants are selected from the group consist ing of vitamin A and derivatives, vitamin C and derivatives, tocopherol and derivatives, pref erably tocopheryl acetate, and ubiquinone.

[0063] Matrix-Metalloproteinase inhibitors (MMPI). Preferred compositions comprise ma trix-metalloproteinase inhibitors, especially those inhibiting matrix-metalloproteinases enzy matically cleaving collagen, selected from the group consisting of: ursolic acid, retinyl palmi tate, propyl gallate, precocenes, 6-hydroxy-7-methoxy-2,2-dimethyl-l(2H)-benzopyran, 3,4- dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-l(2H)-benzopyran, benzamidine hydrochloride, the cysteine proteinase inhibitors N-ethylmalemide and epsilon-amino-n-caproic acid of the serinprotease inhibitors: phenylmethylsufonylfluoride, collhibin (company Pentapharm; I NCI : hydrolysed rice protein), oenotherol (company Soliance; I NCI : propylene glycol, aqua, Oeno thera biennis root extract, ellagic acid and ellagitannins, for example from pomegranate), phosphoramidone hinokitiol, EDTA, galardin, EquiStat (company Collaborative Group; apple fruit extract, soya seed extract, ursolic acid, soya isoflavones and soya proteins), sage extracts, MDI (company Atrium; I NCI : glycosaminoglycans), fermiskin (company Silab/Mawi; I NCI : wa ter and lentinus edodes extract), actimp 1.9.3 (company Expanscience/Rahn; I NCI : hydrolysed lupine protein), lipobelle soyaglycone (company Mibelle; I NCI : alcohol, polysorbate 80, leci thin and soy isoflavones), extracts from green and black tea and further plant extracts, which are listed in WO 02 069992 A1 (see tables 1-12 there, incorporated herein by reference), pro teins or glycoproteins from soya, hydrolysed proteins from rice, pea or lupine, plant extracts which inhibit MMPs, preferably extracts from shitake mushrooms, extracts from the leaves of the Rosaceae family, sub-family Rosoideae, quite particularly extracts of blackberry leaf (preferably as described in WO 2005 123101 Al, incorporated herein by reference) as e.g. SymMatrix (company Symrise, INCI : Maltodextrin, Rubus Fruticosus (Blackberry) Leaf Extract). Preferred actives of are selected from the group consisting of retinyl palmitate, ursolic acid, extracts from the leaves of the Rosaceae family, sub-family Rosoideae, genistein and daidzein.

[0064] Skin-moisturizing agents. Preferred skin moisturizing agents are selected from the group consisting of alkane diols or alkane triols comprising 3 to 12 carbon atoms, preferably C3-Cio-alkane diols and C3-Cio-alkane triols. More preferably the skin moisturizing agents are selected from the group consisting of: glycerol, 1,2-propylene glycol, 1,2-butylene glycol, 1,3- butylene glycol, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol and 1,2-decanediol.

[0065] Glycosaminoglycan stimulators. Preferred compositions comprise substances stimu lating the synthesis of glycosaminoglycans selected from the group consisting of hyaluronic acid and derivatives or salts, Subliskin (Sederma, INCI : Sinorhizobium Meliloti Ferment Filtrate, Cetyl Hydroxyethylcellulose, Lecithin), Hyalufix (BASF, INCI : Water, Butylene Glycol, Alpinia galanga leaf extract, Xanthan Gum, Caprylic/Capric Triglyceride), Stimulhyal (Soliance, INCI : Calcium ketogluconate), Syn-Glycan (DSM, INCI: Tetradecyl Aminobutyroylvalylaminobutyric Urea Trifluoroacetate, Glycerin, Magnesium chloride), Kalpariane (Biotech Marine), DC Upreg- ulex (Distinctive Cosmetic Ingredients, INCI : Water, Butylene Glycol, Phospholipids, Hydro lyzed Sericin), glucosamine, N-acetyl glucosamine, retinoids, preferably retinol and vitamin A, Arctium lappa fruit extract, Eriobotrya japonica extract, Genkwanin, N-Methyl-L-serine, (-)- alpha-bisabolol or synthetic alpha-bisabolol such as e.g. Dragosantol and Dragosantol 100 from Symrise, oat glucan, Echinacea purpurea extract and soy protein hydrolysate. Preferred actives are selected from the group consisting of hyaluronic acid and derivatives or salts, reti nol and derivatives, (-)-alpha-bisabolol or synthetic alpha-bisabolol such as e.g. Dragosantol and Dragosantol 100 from Symrise, oat glucan, Echinacea purpurea extract, Sinorhizobium Meliloti Ferment Filtrate, Calcium ketogluconate, Alpinia galanga leaf extract and tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate. [0066] Anti-inflammatory agents. The compositions may also contain anti-inflammatory and/or redness and/or itch ameliorating ingredients, in particular steroidal substances of the corticosteroid type selected from the group consisting of hydrocortisone, dexamethasone, dexamethasone phosphate, methyl prednisolone or cortisone, are advantageously used as anti-inflammatory active ingredients or active ingredients to relieve reddening and itching, the list of which can be extended by the addition of other steroidal anti-inflammatories. Non steroidal anti-inflammatories can also be used. Examples which can be cited here are oxicams such as piroxicam or tenoxicam; salicylates such as aspirin, disalcid, solprin or fendosal; acetic acid derivatives such as diclofenac, fenclofenac, indomethacin, sulindac, tolmetin or clin- danac; fenamates such as mefenamic, meclofenamic, flufenamic or niflumic; propionic acid derivatives such as ibuprofen, naproxen, benoxaprofen or pyrazoles such as phenylbutazone, oxyphenylbutazone, febrazone or azapropazone. Anthranilic acid derivatives, in particular av- enanthramides described in WO 2004047833 Al, are preferred anti-itch ingredients in a com position according to the present invention.

[0067] Also useful are natural or naturally occurring anti-inflammatory mixtures of substances or mixtures of substances that alleviate reddening and/or itching, in particular extracts or fractions from camomile, Aloe vera, Commiphora species, Rubia species, willow, willow-herb, oats, calendula, arnica, St John's wort, honeysuckle, rosemary, Passiflora incarnata, witch hazel, ginger or Echinacea; preferably selected from the group consisting of extracts or fractions from camomile, Aloe vera, oats, calendula, arnica, honeysuckle, rosemary, witch hazel, ginger or Echinacea, and/or pure substances, preferably alpha-bisabolol, apigenin, apigenin-7-glucoside, gingerols, shogaols, gingerdiols, dehydrogingerdiones, paradols, natural or naturally occuring avenanthramides, preferably tranilast, avenanthramide A, avenanthramide B, avenanthramide C, non-natural or non-naturally occuring avenanthramides, preferably dihydroavenanthramide D, dihydroavenanthramide E, avenanthramide D, avenanthramide E, avenanthramide F, boswellic acid, phytosterols, glycyrrhizin, glabridin and licochalcone A; preferably selected from the group consisting of alpha-bisabolol, natural avenanthramides, non-natural avenanthramides, preferably dihydroavenanthramide D (as described in WO 2004 047833 Al), boswellic acid, phytosterols, glycyrrhizin, and licochalcone A, and/or allantoin, panthenol, lanolin, (pseudo-)ceramides [preferably Ceramide 2, hydroxypropyl bispalmitamide MEA, cetyloxypropyl glyceryl methoxypropyl myristamide, N-(l-hexadecanoyl)-4-hydroxy-L-proline (1-hexadecyl) ester, hydroxyethyl palmityl oxyhydroxypropyl palmitamide], glycosphingolipids, phytosterols, chitosan, mannose, lactose and b-glucans, in particular l,3-l,4^-glucan from oats.

[0068] TRPV1 antagonists. Suitable compounds which reduce the hypersensitivity of skin nerves based on their action as TRPV1 antagonists, encompass e.g. trans-4-tert-butyl cyclohexanol as described in WO 2009 087242 Al, or indirect modulators of TRPV1 by an activation of the m-receptor, e.g. acetyl tetrapeptide-15, are preferred.

[0069] Botanical extracts. The compositions may also contain various extracts of plants, such as for example extracts of Ginkgo biloba, Oleacea europensis, Glyzyrrhiza glabra, Vaccinium myrtillus, Trifolium pratense, Litchi sinensis, Vitis, vinifera, Brassica oleracea, Punica granatum, Petroselinium crispum, Centella asiatica, Passiflora incarnata, Medicago sativa, Melissa officinalis, Valeriana officinalis, Castanea sativa, Salix alba and Hapagophytum procumbens.

COOLING AGENTS

[0070] The compositions may also contain one or more substances with a physiological cool ing effect (cooling agents), which are preferably selected here from the following list: menthol and menthol derivatives (for example L-menthol, D-menthol, racemic menthol, isomenthol, neoisomenthol, neomenthol) menthylethers (for example (l-menthoxy)-l,2-propandiol, (I- menthoxy)-2-methyl-l,2-propandiol, l-menthyl-methylether), menthylesters (for example menthylformiate, menthylacetate, menthylisobutyrate, menthyllactates, L-menthyl-L-lactate, L-menthyl-D-lactate, menthyl-(2-methoxy)acetate, menthyl-(2-methoxyethoxy)acetate, menthylpyroglutamate), menthylcarbonates (for example menthylpropyleneglycolcarbonate, menthylethyleneglycolcarbonate, menthylglycerolcarbonate or mixtures thereof), the semi esters of menthols with a dicarboxylic acid or derivatives thereof (for example mono- menthylsuccinate, mono-menthylglutarate, mono-menthylmalonate, O-menthyl succinic acid ester-N,N-(dimethyl)amide, O-menthyl succinic acid ester amide), menthanecarboxylic acid amides (in this case preferably menthanecarboxylic acid-N-ethylamide [WS3] or N ^a -(men- thanecarbonyl)glycinethylester [WS5], as described in US 4,150,052, menthanecarboxylic acid-N-(4-cyanophenyl)amide or menthanecarboxylic acid-N-(4-cyanomethylphenyl)amide as described in WO 2005 049553 Al, methanecarboxylic acid-N-(alkoxyalkyl)amides), menthone and menthone derivatives (for example L-menthone glycerol ketal), 2,3-dimethyl-2-(2-pro- pyl)-butyric acid derivatives (for example 2,3-dimethyl-2-(2-propyl)-butyric acid-N-methyla- mide [WS23]), isopulegol or its esters (l-(-)-isopulegol, l-(-)-isopulegolacetate), menthane de rivatives (for example p-menthane-3,8-diol), cubebol or synthetic or natural mixtures, con taining cubebol, pyrrolidone derivatives of cycloalkyldione derivatives (for example 3-methyl- 2(l-pyrrolidinyl)-2-cyclopentene-l-one) or tetrahydropyrimidine-2-one (for example iciline or related compounds, as described in WO 2004/026840), further carboxamides (for example N- (2-(pyridin-2-yl)ethyl)-3-p-menthanecarboxamide or related compounds), (lR,2S,5R)-N-(4- Methoxyphenyl)-5-methyl-2-(l-isopropyl)cyclohexane-carboxami de [WS12], oxamates (pref erably those described in EP 2033688 A2).

ANTI-MICROBIAL AGENTS

[0071] Suitable anti-microbial agents are, in principle, all substances effective against Gram positive bacteria, such as, for example, 4- hydroxybenzoic acid and its salts and esters, N-(4- chlorophenyl)-N'-(3,4- dichlorophenyl)urea, 2,4,4'-trichloro-2'-hydroxy-diphenyl ether (triclo- san), 4-chloro-3, 5-dimethyl-phenol, 2,2'-methylenebis(6-bromo-4- chlorophenol), 3-methyl- 4-(l-methylethyl)phenol, 2-benzyl-4-chloro-phenol, 3-(4-chlorophenoxy)-l, 2-propanediol, 3- iodo-2-propynyl butylcarbamate, chlorhexidine, 3,4,4'-trichlorocarbanilide (TTC), antibacte rial fragrances, thymol, thyme oil, eugenol, oil of cloves, menthol, mint oil, farnesol, phenox- yethanol, glycerol monocaprate, glycerol monocaprylate, glycerol monolaurate (GML), diglyc erol monocaprate (DMC), salicylic acid N-alkylamides, such as, for example, n-octylsalic- ylamide or n- decylsalicylamide.

ENZYME INHIBITORS

[0072] Suitable enzyme inhibitors are, for example, esterase inhibitors. These are preferably trialkyl citrates, such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and, in particular, triethyl citrate (Hydagen CAT). The substances inhibit enzyme activity, thereby reducing the formation of odour. Other substances which are suitable esterase inhib itors are sterol sulfates or phosphates, such as, for example, lanosterol, cholesterol, campes- terol, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and esters thereof, such as, for example, glutaric acid, monoethyl glutarate, diethyl glutarate, adipic acid, mo noethyl adipate, diethyl adipate, malonic acid and diethyl malonate, hydroxycarboxylic acids and esters thereof, such as, for example, citric acid, malic acid, tartaric acid or diethyl tartrate, and zinc glycinate.

ODOUR ABSORBERS AND ANTIPERSPIRANT ACTIVE AGENTS

[0073] Suitable odour absorbers are substances which are able to absorb and largely retain odour-forming compounds. They lower the partial pressure of the individual components, thus also reducing their rate of diffusion. It is important that perfumes must remain unim paired in this process. Odour absorbers are not effective against bacteria. They comprise, for example, as main constituent, a complex zinc salt of ricinoleic acid or specific, largely odour- neutral fragrances which are known to the person skilled in the art as "fixatives", such as, for example, extracts of labdanum or styrax or certain abietic acid derivatives. The odour masking agents are fragrances or perfume oils, which, in addition to their function as odour masking agents, give the deodorants their respective fragrance note. Perfume oils which may be men tioned are, for example, mixtures of natural and synthetic fragrances. Natural fragrances are extracts from flowers, stems and leaves, fruits, fruit peels, roots, woods, herbs and grasses, needles and branches, and resins and balsams. Also suitable are animal products, such as, for example, civet and castoreum. Typical synthetic fragrance compounds are products of the es ter, ether, aldehyde, ketone, alcohol, and hydrocarbon type. Fragrance compounds of the es ter type are, for example, benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phe- nylethyl acetate, linalyl benzoate, benzyl formate, allyl cyclohexylpropionate, styrallyl propio nate and benzyl salicylate. The ethers include, for example, benzyl ethyl ether, and the alde hydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal, the ketones include, for example, the ionones and methyl cedryl ketone, the alcohols include an ethole, citronellol, eugenol, isoeugenol, geraniol, linaool, phenylethyl alcohol and terpineol, and the hydrocarbons include mainly the terpenes and balsams. Preference is, however, given to using mixtures of different fragrances which together produce a pleasing fragrance note. Essential oils of relatively low volatility, which are mostly used as aroma components, are also suitable as perfume oils, e.g. sage oil, camomile oil, oil of cloves, melissa oil, mint oil, cinnamon leaf oil, linden flower oil, juniperberry oil, vetiver oil, olibanum oil, galbanum oil, labdanum oil and lavandin oil. Preference is given to using bergamot oil, dihydromyrcenol, lilial, lyral, cit ronellol, phenylethyl alcohol, a-hexylcinnamaldehyde, geraniol, benzylacetone, cyclamen al dehyde, linalool, boisambrene forte, ambroxan, indole, hedione, sandelice, lemon oil, manda rin oil, orange oil, allyl amyl glycolate, cyclovertal, lavandin oil, clary sage oil, b- damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix coeur, iso-E-super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilat, irotyl and floramat alone or in mixtures.

[0074] Suitable astringent antiperspirant active ingredients are primarily salts of aluminium, zirconium or of zinc. Such suitable antihydrotic active ingredients are, for example, aluminium chloride, aluminium chlorohydrate, aluminium dichlorohydrate, aluminium sesquichlorohy- drate and complex compounds thereof, e.g. with 1,2- propylene glycol, aluminium hydroxy- allantoinate, aluminium chloride tartrate, aluminium zirconium trichlorohydrate, aluminium zirconium tetrachlorohydrate, aluminium zirconium pentachlorohydrate and complex com pounds thereof, e.g. with amino acids, such as glycine.

FILM FORMERS AND ANTI-DANDRUFF AGENTS

[0075] Standard film formers are, for example, chitosan, microcrystalline chitosan, quater- nized chitosan, polyvinyl pyrrolidone, vinyl pyrrolidone/vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid and salts thereof and similar compounds.

[0076] Suitable antidandruff agents are Pirocton Olamin (l-hydroxy-4-methyl-6-(2,4,4-trime- thylpentyl)-2-(lH)-pyridinone monoethanolamine salt), Baypival ^® (Climbazole), Ketoconazol ^® (4-acetyl-l-{4-[2-(2,4-dichlorophenyl) r-2-(lH-imidazol-l-ylmethyl)-l,3-dioxylan-c-4-ylmeth- oxyphenylj-piperazine, ketoconazole, elubiol, selenium disulfide, colloidal sulfur, sulfur poly ethylene glycol sorbitan monooleate, sulfur ricinol polyethoxylate, sulfur tar distillate, salicylic acid (or in combination with hexachlorophene), undecylenic acid, monoethanolamide sul- fosuccinate Na salt, Lamepon ^® UD (protein/undecylenic acid condensate), zinc pyrithione, al uminium pyrithione and magnesium pyrithione/dipyrithione magnesium sulfate. CARRIERS AND HYDROTROPES

[0077] Preferred cosmetics carrier materialsare solid or liquid at 25°C and 1013 mbar (includ ing highly viscous substances) as for example glycerol, 1,2-propylene glycol, 1,2-butylene gly col, 1,3-propylene glycol, 1,3-butylene glycol, ethanol, water and mixtures of two or more of said liquid carrier materials with water. Optionally, these preparations according to the inven tion may be produced using preservatives or solubilizers. Other preferred liquid carrier sub stances, which may be a component of a preparation according to the invention are selected from the group consisting of oils such as vegetable oil, neutral oil and mineral oil.

[0078] Preferred solid carrier materials, which may be a component of a preparation accord ing to the invention are hydrocolloids, such as starches, degraded starches, chemically or phys ically modified starches, dextrins, (powdery) maltodextrins (preferably with a dextrose equiv alent value of 5 to 25, preferably of 10 - 20), lactose, silicon dioxide, glucose, modified cellu loses, gum arabic, ghatti gum, traganth, karaya, carrageenan, pullulan, curdlan, xanthan gum, gellan gum, guar flour, carob bean flour, alginates, agar, pectin and inulin and mixtures of two or more of these solids, in particular maltodextrins (preferably with a dextrose equivalent value of 15 - 20), lactose, silicon dioxide and/or glucose.

[0079] In addition, hydrotropes, for example ethanol, isopropyl alcohol or polyols, may be used to improve flow behaviour. Suitable polyols preferably contain 2 to 15 carbon atoms and at least two hydroxyl groups. The polyols may contain other functional groups, more espe cially amino groups, or may be modified with nitrogen. Typical examples are

• glycerol;

• alkylene glycols such as, for example, ethylene glycol, diethylene glycol, propylene gly col, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1000 Dalton;

• technical oligoglycerol mixtures with a degree of self-condensation of 1.5 to 10, such as for example technical diglycerol mixtures with a diglycerol content of 40 to 50% by weight;

• methylol compounds such as, in particular, trimethylol ethane, trimethylol propane, tri- methylol butane, pentaerythritol and dipentaerythritol;

• lower alkyl glucosides, particularly those containing 1 to 8 carbon atoms in the alkyl group, for example methyl and butyl glucoside;

• sugar alcohols containing 5 to 12 carbon atoms, for example sorbitol or mannitol,

• sugars containing 5 to 12 carbon atoms, for example glucose or sucrose;

• amino sugars, for example glucamine;

• dialcoholamines, such as diethanolamine or 2-aminopropane-l,3-diol. PERFUME OILS AND FRAGRANCES

[0080] Suitable perfume oils are mixtures of natural and synthetic perfumes. Natural per fumes include the extracts of blossoms (lily, lavender, rose, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, orange), roots (nutmeg, angelica, celery, cardamom, costus, iris, calmus), woods (pinewood, sandalwood, guaiac wood, cedarwood, rosewood), herbs and grasses (tarragon, lemon grass, sage, thyme), needles and branches (spruce, fir, pine, dwarf pine), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax). Animal raw materials, for example civet and beaver, may also be used. Typical synthetic perfume compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Examples of perfume compounds of the ester type are benzyl acetate, phenoxyethyl isobutyr ate, p-tert. butyl cyclohexylacetate, linalyl acetate, dimethyl benzyl carbinyl acetate, phenyl ethyl acetate, linalyl benzoate, benzyl formate, ethylmethyl phenyl glycinate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate. Ethers include, for example, benzyl ethyl ether while aldehydes include, for example, the linear alkana Is containing 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal. Examples of suitable ketones are the ionones, Glisomethylionone and methyl cedryl ketone. Suitable alcohols are anethol, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol. The hydrocarbons mainly include the terpenes and balsams. However, it is preferred to use mixtures of different perfume compounds which, together, produce an agreeable perfume. Other suitable perfume oils are essential oils of relatively low volatility which are mostly used as aroma components. Examples are sage oil, camomile oil, clove oil, melissa oil, mint oil, cinnamon leaf oil, lime-blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil, ladanum oil and lavendin oil. The following are preferably used either individually or in the form of mixtures: bergamot oil, dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, hexylcinnamaldehyde, geraniol, benzyl acetone, cyclamen aldehyde, linalool, Boisambrene Forte, Ambroxan, indole, hedione, sandelice, citrus oil, mandarin oil, orange oil, allylamyl glycolate, cyclovertal, lavendin oil, clary oil, damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romillat, irotyl and floramat.

DYES

[0081] Suitable dyes are any of the substances suitable and approved for cosmetic purposes as listed, for example, in the publication "Kosmetische Farbemittel" of the Farbstoff- kommission der Deutschen Forschungsgemeinschaft, Verlag Chemie, Weinheim, 1984, pages 81 to 106. Examples include cochineal red A (C.l. 16255), patent blue V (C.l. 42051), indigotin (C.l. 73015), chlorophyllin (C.l. 75810), quinoline yellow (C.l. 47005), titanium dioxide (C.l. 77891), indanthrene blue RS (C.l. 69800) and madder lake (C.l. 58000). Luminol may also be present as a luminescent dye. Advantageous coloured pigments are for example titanium dioxide, mica, iron oxides (e.g. Fe ₂ 03 Fe30 ₄ , FeO(OH)) and/or tin oxide. Advantageous dyes are for example carmine, Berlin blue, chromium oxide green, ultramarine blue and/or manganese violet.

[0082] Preferred compositions according to the present inventions are selected from the group of products for treatment, protecting, care and cleansing of the skin and/or hair or as a make-up product, preferably as a leave-on product (meaning that the one or more compounds of formula (I) stay on the skin and/or hair for a longer period of time, compared to rinse-off products, so that the moisturizing and/or anti-ageing and/or wound healing promoting action thereof is more pronounced).

[0083] The formulations according to the invention are preferably in the form of an emulsion, e.g. W/O (water-in-oil), O/W (oil-in-water), W/O/W (water-in-oil-in-water), O/W/O (oil-in- water-in-oil) emulsion, PIT emulsion, Pickering emulsion, emulsion with a low oil content, micro- or nanoemulsion, a solution, e.g. in oil (fatty oils or fatty acid esters, in particular C ₆ - C32 fatty acid C2-C30 esters) or silicone oil, dispersion, suspension, creme, lotion or milk, depending on the production method and ingredients, a gel (including hydrogel, hydrodispersion gel, oleogel), spray (e.g. pump spray or spray with propellant) or a foam or an impregnating solution for cosmetic wipes, a detergent, e.g. soap, synthetic detergent, liquid washing, shower and bath preparation, bath product (capsule, oil, tablet, salt, bath salt, soap, etc.), effervescent preparation, a skin care product such as e.g. an emulsion (as described above), ointment, paste, gel (as described above), oil, balsam, serum, powder (e.g. face powder, body powder), a mask, a pencil, stick, roll-on, pump, aerosol (foaming, non foaming or post-foaming), a deodorant and/or antiperspirant, mouthwash and mouth rinse, a foot care product (including keratolytic, deodorant), an insect repellent, a sunscreen, aftersun preparation, a shaving product, aftershave balm, pre- and aftershave lotion, a depilatory agent, a hair care product such as e.g. sha mpoo (including 2-in-l shampoo, anti dandruff shampoo, baby shampoo, shampoo for dry scalps, concentrated shampoo), conditioner, hair tonic, hair water, hair rinse, styling creme, pomade, perm and setting lotion, hair spray, styling aid (e.g. gel or wax), hair smoothing agent (detangling agent, relaxer), hair dye such as e.g. temporary direct-dyeing hair dye, semi-permanent hair dye, permanent hair dye, hair conditioner, hair mousse, eye care product, make-up, make-up remover or baby product.

[0084] The formulations according to the invention are particularly preferably in the form of an emulsion, in particular in the form of a W/O, O/W, W/O/W, O/W/O emulsion, PIT emulsion, Pickering emulsion, emulsion with a low oil content, micro- or nanoemulsion, a gel (including hydrogel, hydrodispersion gel, oleogel), a solution e.g. in oil (fatty oils or fatty acid esters, in particular C6-C32 fatty acid C2-C30 esters)) or silicone oil, or a spray (e.g. pump spray or spray with propellant). [0085] Auxiliary substances and additives can be included in quantities of 5 to 99 % b.w., preferably 10 to 80 % b.w., based on the total weight of the formulation. The amounts of cosmetic or dermatological auxiliary agents and additives and perfume to be used in each case can easily be determined by the person skilled in the art by simple trial and error, depending on the nature of the particular product.

[0086] The preparations can also contain water in a quantity of up to 99 % b.w., preferably 5 to 80 % b.w., based on the total weight of the preparation.

DETERGENT COMPOSITIONS

[0087] Another embodiment of the present invention covers a detergent composition com prising a working amount of at least one acetophenone derivative or its mixtures with addi tional preservatives and/or antimicrobial agents, which might be present in amounts of from about 0.01 to about 10, preferably about 0.05 to about 5 and more preferably about 0.1 to about 1 % b.w. - calculated on the total composition.

[0088] The detergent compositions according to the present invention may comprise any of the ingredients customarily found in such compositions, such as, for example, anionic, nonionic, cationic, amphoteric or zwitterionic (co-)surfactants, organic solvents, builders, en zymes and additional auxiliaries such as soil repellents, thickeners, colorants and fragrances or the like.

ANIONIC CO-SURFACTANTS

[0089] Preferably, surfactants of the sulfonate type, alk(en)yl sulfonates, alkoxylated alk(en)yl sulfates, ester sulfonates and/or soaps are used as the anionic surfactants. Suitable surfac tants of the sulfonate type are advantageously C9-13 alkylbenzene sulfonates, olefin sulfonates, i.e. mixtures of alkene- and hydroxyalkane sulfonates, and disulfonates, as are obtained, for example, by the sulfonation with gaseous sulfur trioxide of C12-18 monoolefins having a termi nal or internal double bond and subsequent alkaline or acidic hydrolysis of the sulfonation products.

[0090] Alk(en)yl sulfates. Preferred alk(en)yl sulfates are the alkali and especially the sodium salts of the sulfuric acid half-esters of the C12-C18 fatty alcohols, for example, from coconut butter alcohol, tallow alcohol, lauryl, myristyl, cetyl or stearyl alcohol or from C8-C20 oxo alco hols and those half-esters of secondary alcohols of these chain lengths. Alk(en)yl sulfates of the cited chain lengths that comprise a synthetic straight chain alkyl group manufactured pet- rochemically are also preferred. The C12-C16 alkyl sulfates and C12-C15 alkyl sulfates as well as C14-C15 alkyl sulfates and C14-C16 alkyl sulfates are particularly preferred on the grounds of laundry performance. The 2,3-alkyl sulfates, which can be obtained from Shell Oil Company under the trade name DAN™, are also suitable anionic surfactants. [0091] Alk(en)yl ether sulfates. Sulfuric acid mono-esters derived from straight-chained or branched C ₇ -C ₂₁ alcohols ethoxylated with 1 to 6 moles ethylene oxide are also suitable, such as 2-methyl-branched C ₉ -C ₁₁ alcohols with an average of 3.5 mol ethylene oxide (EO) or C ₁₂ - Ci8 fatty alcohols with 1 to 4 EO.

[0092] Ester sulfonates. The esters of alpha-sulfo fatty acids (ester sulfonates), e.g., the alpha- sulfonated methyl esters of hydrogenated coco-, palm nut- or tallow acids are likewise suita ble.

[0093] Soaps. Soaps, in particular, can be considered as further anionic surfactants. Saturated fatty acid soaps are particularly suitable, such as the salts of lauric acid, myristic acid, palmitic acid, stearic acid, hydrogenated erucic acid and behenic acid, and especially soap mixtures derived from natural fatty acids such as coconut oil fatty acid, palm kernel oil fatty acid or tallow fatty acid. Those soap mixtures are particularly preferred that are composed of 50 to 100 wt. % of saturated C12-C24 fatty acid soaps and 0 to 50 wt. % of oleic acid soap.

[0094] Ether carboxylic acids. A further class of anionic surfactants is that of the ether car boxylic acids, obtainable by treating fatty alcohol ethoxylates with sodium chloroacetate in the presence of basic catalysts. They have the general formula: ROiCI-hCI-hOj _p CI-hCOOH with R = C ₁ -C ₁₈ and p = 0.1 to 20. Ether carboxylic acids are insensitive to water hardness and pos sess excellent surfactant properties.

NONIONIC (CO-)SURFACTANTS

[0095] Alkohol alkoxylates. The added nonionic surfactants are preferably a I koxylated and/or propoxylated, particularly primary alcohols having preferably 8 to 18 carbon atoms and an average of 1 to 12 mol ethylene oxide (EO) and/or 1 to 10 mol propylene oxide (PO) per mol alcohol. Cs-Ci ₆ -Alcohol alkoxylates, advantageously ethoxylated and/or propoxylated C10-C15- alcohol alkoxylates, particularly C12-C14 alcohol alkoxylates, with an ethoxylation degree be tween 2 and 10, preferably between 3 and 8, and/or a propoxylation degree between 1 and 6, preferably between 1.5 and 5, are particularly preferred. The cited degrees of ethoxylation and propoxylation constitute statistical average values that can be a whole or a fractional number for a specific product. Preferred alcohol ethoxylates and propoxylates have a nar rowed homolog distribution (narrow range ethoxylates/propoxylates, NRE/NRP). In addition to these nonionic surfactants, fatty alcohols with more than 12 EO can also be used. Examples of these are (tallow) fatty alcohols with 14 EO, 16 EO, 20 EO, 25 EO, 30 EO or 40 EO.

[0096] Alkylglycosides (APG ^® ). Furthermore, as additional nonionic surfactants, alkyl glyco sides that satisfy the general Formula RO(G) _x , can be added, e.g., as compounds, particularly with anionic surfactants, in which R means a primary linear or methyl-branched, particularly 2-methyl-branched, aliphatic group containing 8 to 22, preferably 12 to 18 carbon atoms and G stands for a glycose unit containing 5 or 6 carbon atoms, preferably for glucose. The degree of oligomerization x, which defines the distribution of monoglycosides and oligoglycosides, is any number between 1 and 10, preferably between 1.1 and 1.4.

[0097] Fatty acid ester alkoxylates. Another class of preferred nonionic surfactants, which are used either as the sole nonionic surfactant or in combination with other nonionic surfac tants, in particular, together with alkoxylated fatty alcohols and/or alkyl glycosides, are alkox- ylated, preferably ethoxylated or ethoxylated and propoxylated fatty acid alkyl esters prefer ably containing 1 to 4 carbon atoms in the alkyl chain, more particularly the fatty acid methyl esters which are described, for example, in Japanese Patent Application JP-A-58/217598 or which are preferably produced by the process described in International Patent Application WO-A-90/13533. Methyl esters of C12-C18 fatty acids containing an average of 3 to 15 EO, par ticularly containing an average of 5 to 12 EO, are particularly preferred.

[0098] Amine oxides. Nonionic surfactants of the amine oxide type, for example, N-coco alkyl-N,N-dimethylamine oxide and N-tallow alkyl-N,N-dihydroxyethylamine oxide, and the fatty acid alkanolamides may also be suitable. The quantity in which these nonionic surfac tants are used is preferably no more than the quantity in which the ethoxylated fatty alcohols are used and, particularly no more than half that quantity.

[0099] Gemini surfactants. The so-called gemini surfactants can be considered as further surfactants. Generally speaking, such compounds are understood to mean compounds that have two hydrophilic groups and two hydrophobic groups per molecule. As a rule, these groups are separated from one another by a "spacer". The spacer is usually a hydrocarbon chain that is intended to be long enough such that the hydrophilic groups are a sufficient dis tance apart to be able to act independently of one another. These types of surfactants are generally characterized by an unusually low critical micelle concentration and the ability to strongly reduce the surface tension of water. In exceptional cases, however, not only dimeric but also trimeric surfactants are meant by the term gemini surfactants. Suitable gemini sur factants are, for example, sulfated hydroxy mixed ethers according to German Patent Appli cation DE 4321022 A1 or dimer alcohol bis- and trimer alcohol tris sulfates and ether sulfates according to International Patent Application WO 96/23768 Al. Blocked end group dimeric and trimeric mixed ethers according to German Patent Application DE 19513391 Al are espe cially characterized by their bifunctionality and multifunctionality. Gemini polyhydroxyfatty acid amides or polyhydroxyfatty acid amides, such as those described in International Patent Applications WO 95/19953 Al, WO 95/19954 Al and WO 95/19955 Al can also be used.

CATIONIC -SURFACTANTS

[00100] Tetraalkyl ammonium salts. Cationically active surfactants comprise the hydropho bic high molecular group required for the surface activity in the cation by dissociation in aque ous solution. A group of important representatives of the cationic surfactants are the tetraalkyl ammonium salts of the general formula: (R ¹ R ² R ³ R ⁴ N ⁺ ) X . Here R1 stands for Ci-Cs alk(en)yl, R ² , R ³ and R ⁴ , independently of each other, for alk(en)yl radicals having 1 to 22 car bon atoms. X is a counter ion, preferably selected from the group of the halides, alkyl sulfates and alkyl carbonates. Cationic surfactants, in which the nitrogen group is substituted with two long acyl groups and two short alk(en)yl groups, are particularly preferred.

[00101] Esterquats. A further class of cationic surfactants particularly useful as co-surfactants for the present invention is represented by the so-called esterquats. Esterquats are generally understood to be quaternised fatty acid triethanolamine ester salts. These are known com pounds which can be obtained by the relevant methods of preparative organic chemistry. Ref erence is made in this connection to International patent application WO 91/01295 Al, ac cording to which triethanolamine is partly esterified with fatty acids in the presence of hypo- phosphorous acid, air is passed through the reaction mixture and the whole is then quater nised with dimethyl sulphate or ethylene oxide. In addition, German patent DE 4308794 Cl describes a process for the production of solid esterquats in which the quaternisation of tri ethanolamine esters is carried out in the presence of suitable dispersants, preferably fatty alcohols.

[00102] Typical examples of esterquats suitable for use in accordance with the invention are products of which the acyl component derives from monocarboxylic acids corresponding to formula RCOOH in which RCO is an acyl group containing 6 to 10 carbon atoms, and the amine component is triethanolamine (TEA). Examples of such monocarboxylic acids are caproic acid, caprylic acid, capric acid and technical mixtures thereof such as, for example, so-called head- fractionated fatty acid. Esterquats of which the acyl component derives from monocarboxylic acids containing 8 to 10 carbon atoms, are preferably used. Other esterquats are those of which the acyl component derives from dicarboxylic acids like malonic acid, succinic acid, ma leic acid, fumaric acid, glutaric acid, sorbic acid, pimelic acid, azelaic acid, sebacic acid and/or dodecanedioic acid, but preferably adipic acid. Overall, esterquats of which the acyl compo nent derives from mixtures of monocarboxylic acids containing 6 to 22 carbon atoms, and adipic acid are preferably used. The molar ratio of mono and dicarboxylic acids in the final esterquat may be in the range from 1:99 to 99:1 and is preferably in the range from 50:50 to 90:10 and more particularly in the range from 70:30 to 80:20. Besides the quaternised fatty acid triethanolamine ester salts, other suitable esterquats are quaternized ester salts of mono- /dicarboxylic acid mixtures with diethanolalkyamines or 1,2-dihydroxypropyl dialkylamines. The esterquats may be obtained both from fatty acids and from the corresponding triglycer ides in admixture with the corresponding dicarboxylic acids. One such process, which is in tended to be representative of the relevant prior art, is proposed in European patent EP 0750606 Bl. To produce the quaternised esters, the mixtures of mono- and dicarboxylic acids and the triethanolamine - based on the available carboxyl functions - may be used in a molar ratio of 1.1:1 to 3:1. With the performance properties of the esterquats in mind, a ratio of 1.2:1 to 2.2:1 and preferably 1.5:1 to 1.9:1 has proved to be particularly advantageous. The preferred esterquats are technical mixtures of mono-, di- and triesters with an average degree of esterification of 1.5 to 1.9. AMPHOTERIC OR ZWITTERIONIC CO-SURFACTANTS

[00103] Betaines. Amphoteric or ampholytic surfactants possess a plurality of functional groups that can ionize in aqueous solution and thereby-depending on the conditions of the medium-lend anionic or cationic character to the compounds (see DIN 53900, July 1972). Close to the isoelectric point (around pH 4), the amphoteric surfactants form inner salts, thus becoming poorly soluble or insoluble in water. Amphoteric surfactants are subdivided into ampholytes and betaines, the latter existing as zwitterions in solution. Ampholytes are am photeric electrolytes, i.e. compounds that possess both acidic as well as basic hydrophilic groups and therefore behave as acids or as bases depending on the conditions. Especially be taines are known surfactants which are mainly produced by carboxyalkylation, preferably car- boxymethylation, of amine compounds. The starting materials are preferably condensed with halocarboxylic acids or salts thereof, more particularly sodium chloroacetate, one mole of salt being formed per mole of betaine. The addition of unsaturated carboxylic acids, such as acrylic acid for example, is also possible. Examples of suitable betaines are the carboxy alkylation products of secondary and, in particular, tertiary amines which correspond to formula R ¹ R ² R ³ N-(CH ₂ ) _q COOX where R ¹ is a an alkyl radical having 6 to 22 carbon atoms, R ² is hydrogen or an alkyl group containing 1 to 4 carbon atoms, R ³ is an alkyl group containing 1 to 4 carbon atoms, q is a number of 1 to 6 and X is an alkali and/or alkaline earth metal or ammonium. Typical examples are the carboxymethylation products of hexylmethylamine, hexyldimethyl- amine, octyldimethylamine, decyldimethylamine, Ci2/i ₄ -cocoalkyldimethylamine, myri- styldimethylamine, cetyldimethylamine, stearyldimethylamine, stearylethylmethylamine, oleyldimethylamine, Ci ₆ /i ₈ -tallowalkyldimethylamine and their technical mixtures, and partic ularly dodecyl methylamine, dodecyl dimethylamine, dodecyl ethylmethylamine and technical mixtures thereof.

[00104] Alkylamido betaines. Other suitable betaines are the carboxyalkylation products of amidoamines corresponding to formula R ¹ CO(R ³ )(R ⁴ )-NH-(CH2) _P -N-(CH2) _q COOX in which R ¹ CO is an aliphatic acyl radical having 6 to 22 carbon atoms and 0 or 1 to 3 double bonds, R ² is hydrogen or an alkyl radical having 1 to 4 carbon atoms, R ³ is an alkyl radical having 1 to 4 carbon atoms, p is a number from 1 to 6, q is a number from 1 to 3 and X is an alkali and/or alkaline earth metal or ammonium. Typical examples are reaction products of fatty acids hav ing 6 to 22 carbon atoms, like for example caproic acid, caprylic acid, caprinic acid, lauric acid, myristic acid, palmitic acid, palmoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linolic acid linoleic acid, elaeostearic acid, arachidonic acid, gadoleic acid, behenic acid, erucic acid and their technical mixtures with N,N-dimethylaminoethylamine, N,N-dimethylaminopropylamine, N,N-diethylaminoethylamine und N,N-diethylaminopropyl- amine, which are condensed with sodium chloroacetate. The commercially available products include Dehyton ^® K and Dehyton ^® PK (Cognis Deutschland GmbH & Co., KG) as well as Tego ^® Be- taine (Goldschmidt). [00105] Imidazolines. Other suitable starting materials for the betaines to be used for the purposes of the invention are imidazolines. These substances are also known and may be ob tained, for example, by cyclizing condensation of 1 or 2 moles of C6 C22 fatty acids with poly functional amines, such as for example aminoethyl ethanolamine (AEEA) or diethylenetri- amine. The corresponding carboxyalkylation products are mixtures of different open-chain betaines. Typical examples are condensation products of the above- mentioned fatty acids with AEEA, preferably imidazolines based on lauric acid, which are subsequently betainised with sodium chloroacetate. The commercially available products include Dehyton ^® G (Cognis Deutschland GmbH & Co., KG)

[00106] The amount of (co-)surfactant comprised in the inventive compositions is advanta geously 0.1 wt. % to 90 wt. %, particularly 10 wt. % to 80 wt. % and particularly preferably 20 wt. % to 70 wt.-%.

ORGANIC SOLVENT

[00107] Liquid light or heavy duty detergents may comprise organic solvents, preferably those miscible with water. Polydiols, ethers, alcohols, ketones, amides and/or esters are preferably used as the organic solvent for this in amounts of 0 to 90 wt. %, preferably 0.1 to 70 wt. %, particularly 0.1 to 60 wt. %. Low molecular weight polar substances, such as for example, methanol, ethanol, propylene carbonate, acetone, acetonylacetone, diacetone alcohol, ethyl acetate, 2-propanol, ethylene glycol, propylene glycol, glycerin, diethylene glycol, dipropylene glycol monomethyl ether and dimethylformamide or their mixtures are preferred.

ENZYMES

[00108] Suitable enzymes include, in particular, those from the classes of hydrolases, such as proteases, esterases, lipases or lipolytic enzymes, amylases, cellulases or other glycosyl hydro lases and mixtures thereof. In the wash, all these hydrolases contribute to removing stains such as protein, fat or starchy stains and against graying. Moreover, cellulases and other gly cosyl hydrolases can contribute to increased softness of the textile and to color retention by removing pilling and micro fibrils. Oxidoreductases can also be added to the bleaches or to inhibit the color transfer. Enzymatic active materials obtained from bacterial sources or fungi such as bacillus subtilis, bacillus licheniformis, streptomyceus griseus and humicola insolens are particularly well suited. Proteases of the subtilisin type and particularly proteases that are obtained from bacillus lentus are preferably used. Here, mixtures of enzymes are of particular interest, for example, proteases and amylases or proteases and lipases or lipolytic enzymes or proteases and cellulases or cellulases and lipase or lipolytic enzymes or proteases, amylases and lipases or lipolytic enzymes or proteases, lipases or lipolytic enzymes and cellulases, in particular, however proteases and/or lipase-containing mixtures or mixtures with lipolytic en zymes. Examples of such lipolytic enzymes are the known cutinases. Peroxidases or oxidases have also proved to be suitable in certain cases. The suitable amylases particularly include .alpha. -amylases, iso-amylases, pullulanases and pectinases. Cellobiohydrolases, endoglu- canases and .beta.-glucosidases or mixtures thereof, which are also known as cellobiases, are preferred cellulases. As the different cellulase types differ in their CMCase and avicelase ac tivities, the required activities can be adjusted by controlled mixtures of the cellulases. The content of the enzymes or enzyme mixtures may be, for example, about 0.1 to 5% by weight and is preferably 0.1 to about 3% by weight.

BUILDERS

[00109] Zeolites. Fine crystalline, synthetic zeolites containing bound water can be used as builders, for example, preferably zeolite A and/or P. Zeolite MAP.RTM. (commercial product of the Crosfield company), is particularly preferred as the zeolite P. However, zeolite X and mixtures of A, X, Y and/or P are also suitable. A co-crystallized sodium/potassium aluminum silicate from Zeolite A and Zeolite X, which is available as Vegobond ^® RX. (commercial product from Condea Augusta S.p.A.), is also of particular interest. Preferably, the zeolite can be used as a spray-dried powder. For the case where the zeolite is added as a suspension, this can comprise small amounts of nonionic surfactants as stabilizers, for example, 1 to 3 wt. %, based on the zeolite, of ethoxylated C12-C18 fatty alcohols with 2 to 5 ethylene oxide groups, C12-C14 fatty alcohols with 4 to 5 ethylene oxide groups or ethoxylated isotridecanols. Suitable zeolites have an average particle size of less than lOpm (test method: volumetric distribution Coulter counter) and preferably comprise 18 to 22 wt. %, particularly 20 to 22 wt. % of bound water. Apart from this, phosphates can also be used as builders.

[00110] Layered silicates. Suitable substitutes or partial substitutes for phosphates and zeo lites are crystalline, layered sodium silicates. These types of crystalline layered silicates are described, for example, in European Patent Application EP 0164514 Al. Preferred crystalline layered silicates are those obtained for example, from the process described in International Patent Application WO 91/08171 Al.

[00111] Amorphous silicates. Preferred builders also include amorphous sodium silicates with a modulus (Na ₂ 0:Si0 ₂ ratio) of 1:2 to 1:3.3, preferably 1:2 to 1:2.8 and more preferably 1:2 to 1:2.6, which dissolve with a delay and exhibit multiple wash cycle properties. The delay in dissolution compared with conventional amorphous sodium silicates can have been ob tained in various ways, for example, by surface treatment, compounding, compressing/com pacting or by over-drying. In the context of this invention, the term "amorphous" also means "X-ray amorphous". In other words, the silicates do not produce any of the sharp X-ray reflex ions typical of crystalline substances in X-ray diffraction experiments, but at best one or more maxima of the scattered X-radiation, which have a width of several degrees of the diffraction angle. However, particularly good builder properties may even be achieved where the silicate particles produce indistinct or even sharp diffraction maxima in electron diffraction experi- ments. This is to be interpreted to mean that the products have microcrystalline regions be tween 10 and a few hundred nm in size, values of up to at most 50 nm and especially up to at most 20 nm being preferred. This type of X-ray amorphous silicates, which similarly possess a delayed dissolution in comparison with the customary water glasses, are described, for exam ple, in German Patent Application DE 4400024 Al. Compacted/densified amorphous silicates, compounded amorphous silicates and over dried X-ray-amorphous silicates are particularly preferred.

[00112] Phosphates. Also the generally known phosphates can also be added as builders, in so far that their use should not be avoided on ecological grounds. The sodium salts of the orthophosphates, the pyrophosphates and especially the tripolyphosphates are particularly suitable. Their content is generally not more than 25 wt. %, preferably not more than 20 wt. %, each based on the finished composition. In some cases it has been shown that particularly tripolyphosphates, already in low amounts up to maximum 10 wt. %, based on the finished composition, in combination with other builders, lead to a synergistic improvement of the secondary washing power. Preferred amounts of phosphates are under 10 wt. %, particularly 0 wt. %.

CO-BUILDERS

[00113] Polycarboxylic acids. Useful organic cobuilders are, for example, the polycarboxylic acids usable in the form of their sodium salts of polycarboxylic acids, wherein polycarboxylic acids are understood to be carboxylic acids that carry more than one acid function. These include, for example, citric acid, adipic acid, succinic acid, glutaric acid, malic acid, tartaric acid, maleic acid, fumaric acid, sugar acids, aminocarboxylic acids, nitrilotriacetic acid (NTA) and its derivatives and mixtures thereof. Preferred salts are the salts of polycarboxylic acids such as citric acid, adipic acid, succinic acid, glutaric acid, tartaric acid, sugar acids and mixtures thereof.

[00114] Organic acids. Acids per se can also be used. Besides their building effect, the acids also typically have the property of an acidifying component and, hence also serve to establish a relatively low and mild pH in detergents or cleansing compositions. Citric acid, succinic acid, glutaric acid, adipic acid, gluconic acid and any mixtures thereof are particularly mentioned in this regard. Further suitable acidifiers are the known pH regulators such as sodium hydrogen carbonate and sodium hydrogen sulfate.

[00115] Polymers. Particularly suitable polymeric cobuilders are polyacrylates, which prefer ably have a molecular weight of 2,000 to 20,000 g/mol. By virtue of their superior solubility, preferred representatives of this group are again the short-chain polyacrylates, which have molecular weights of 2,000 to 10,000 g/mol and, more particularly, 3,000 to 5,000 g/mol. Suit able polymers can also include substances that consist partially or totally of vinyl alcohol units or its derivatives.

[00116] Further suitable copolymeric polycarboxylates are particularly those of acrylic acid with methacrylic acid and of acrylic acid or methacrylic acid with maleic acid. Copolymers of acrylic acid with maleic acid, which comprise 50 to 90 wt. % acrylic acid and 50 to 10 wt. % maleic acid, have proven to be particularly suitable. Their relative molecular weight, based on free acids, generally ranges from 2,000 to 70,000 g/mol, preferably 20,000 to 50,000 g/mol and especially 30,000 to 40,000 g/mol. The (co)polymeric polycarboxylates can be added ei ther as an aqueous solution or preferably as powder. In order to improve the water solubility, the polymers can also comprise allylsulfonic acids as monomers, such as, for example, al- lyloxybenzene sulfonic acid and methallyl sulfonic acid as in the EP 0727448 Bl.

[00117] Biodegradable polymers comprising more than two different monomer units are par ticularly preferred, examples being those comprising, as monomers, salts of acrylic acid and of maleic acid, and also vinyl alcohol or vinyl alcohol derivatives, as in DE 4300772 Al, or those comprising, as monomers, salts of acrylic acid and of 2-alkylallyl sulfonic acid, and also sugar derivatives. Further preferred copolymers are those that are described in German Patent Ap plications DE 4303320 Al and DE 4417734 Al and preferably include acrolein and acrylic acid/acrylic acid salts or acrolein and vinyl acetate as monomers.

[00118] Similarly, other preferred builders are polymeric aminodicarboxylic acids, salts or pre cursors thereof. Those polyaspartic acids or their salts and derivatives disclosed in German Patent Application DE 19540086 Al as having a bleach-stabilizing action in addition to cobuilder properties are particularly preferred.

[00119] Further suitable builders are polyacetals that can be obtained by treating dialdehydes with polyol carboxylic acids that possess 5 to 7 carbon atoms and at least 3 hydroxyl groups, as described in European Patent Application EP 0280223 Al. Preferred polyacetals are ob tained from dialdehydes like glyoxal, glutaraldehyde, terephthalaldehyde as well as their mix tures and from polycarboxylic acids like gluconic acid and/or glucoheptonic acid.

[00120] Carbohydrates. Further suitable organic cobuilders are dextrins, for example, oligo mers or polymers of carbohydrates that can be obtained by the partial hydrolysis of starches. The hydrolysis can be carried out using typical processes, for example, acidic or enzymatic catalyzed processes. The hydrolysis products preferably have average molecular weights in the range of 400 to 500,000 g/mol. A polysaccharide with a dextrose equivalent (DE) of 0.5 to 40 and, more particularly, 2 to 30 is preferred, the DE being an accepted measure of the re ducing effect of a polysaccharide in comparison with dextrose, which has a DE of 100. Both maltodextrins with a DE between 3 and 20 and dry glucose syrups with a DE between 20 and 37 and also so-called yellow dextrins and white dextrins with relatively high molecular weights of 2,000 to 30,000 g/mol may be used. A preferred dextrin is described in British Patent Appli cation 94 19 091.

[00121] The oxidized derivatives of such dextrins concern their reaction products with oxidiz ing compositions that are capable of oxidizing at least one alcohol function of the saccharide ring to the carboxylic acid function. Such oxidized dextrins and processes for their manufac ture are known for example, from European Patent Applications EP 0232202 Al. A product oxidized at C6 of the saccharide ring can be particularly advantageous.

[00122] Oxydisuccinates and other derivatives of disuccinates, preferably ethylenediamine disuccinate are also further suitable cobuilders. Here, ethylene diamine-N,N'-disuccinate (EDDS), the synthesis of which is described for example, in US 3,158,615, is preferably used in the form of its sodium or magnesium salts. In this context, glycerine disuccinates and glycerine trisuccinates are also particularly preferred, such as those described in US 4,524,009. Suitable addition quantities in zeolite-containing and/or silicate-containing formulations range from 3 to 15% by weight.

[00123] Lactones. Other useful organic co-builders are, for example, acetylated hydroxycar- boxylic acids and salts thereof which optionally may also be present in lactone form and which contain at least 4 carbon atoms, at least one hydroxyl group and at most two acid groups. Such cobuilders are described, for example, in International Patent Application WO 95/20029 Al.

SOIL REPELLENTS

[00124] In addition, the compositions can also comprise components that positively influence the oil and fat removal from textiles during the wash (so-called soil repellents). This effect is particularly noticeable when a textile is dirty and had been previously already washed several times with an inventive detergent that comprised this oil- or fat-removing component. The preferred oil and fat removing components include, for example, nonionic cellulose ethers such as methyl cellulose and methyl hydroxypropyl cellulose with a content of methoxy groups of 15 to 30 wt. % and hydroxypropoxy groups of 1 to 15 wt. %, each based on the nonionic cellulose ether, as well as polymers of phthalic acid and/or terephthalic acid or their deriva tives known from the prior art, particularly polymers of ethylene terephthalates and/or poly ethylene glycol terephtha lates or anionically and/or nonionically modified derivatives thereof. From these, the sulfonated derivatives of the phthalic acid polymers and the terephthalic acid polymers are particularly preferred.

INIORGANIC SALTS

[00125] Further suitable ingredients of the composition are water-soluble inorganic salts such as bicarbonates, carbonates, amorphous silicates or mixtures of these; alkali carbonate and amorphous silicate are particularly used, principally sodium silicate with a molar ratio Na ₂ 0:Si0 ₂ of 1:1 to 1:4.5, preferably of 1:2 to 1:3.5. Preferred compositions comprise alkaline salts, builders and/or cobuilders, preferably sodium carbonate, zeolite, crystalline, layered so dium silicates and/or trisodium citrate, in amounts of 0.5 to 70 wt. %, preferably 0.5 to 50 wt. %, particularly 0.5 to 30 wt. % anhydrous substance.

FOAM INHIBITORS

[00126] Especially when used in automatic washing processes, it can be advantageous to add conventional foam inhibitors to the compositions. Suitable foam inhibitors include for exam ple, soaps of natural or synthetic origin, which have a high content of C18-C24 fatty acids. Suit able non-surface-active types of foam inhibitors are, for example, organopolysiloxanes and mixtures thereof with microfine, optionally silanised silica and also paraffins, waxes, micro crystalline waxes and mixtures thereof with silanised silica or bis-stearyl ethylenediamide. Mixtures of various foam inhibitors, for example, mixtures of silicones, paraffins or waxes, are also used with advantage. Preferably, the foam inhibitors, especially silicone-containing and/or paraffin-containing foam inhibitors, are loaded onto a granular, water-soluble or dis persible carrier material. Especially in this case, mixtures of paraffins and bis-stearylethylene diamides are preferred.

SEQUESTRANTS

[00127] The salts of polyphosphonic acid can be considered as sequestrants or as stabilizers, particularly for peroxy compounds and enzymes, which are sensitive towards heavy metal ions. Here, the sodium salts of, for example, l-hydroxyethane-l,l-diphosphonate, diethylene- triamine pentamethylene phosphonate or ethylenediamine tetramethylene phosphonate are used in amounts of 0.1 to 5 wt. %.

GRAYING INHIBITORS

[00128] Graying inhibitors have the function of maintaining the dirt that was removed from the fibers suspended in the washing liquor, thereby preventing the dirt from resettling. Water- soluble colloids of mostly organic nature are suitable for this, for example, the water-soluble salts of (co)polymeric carboxylic acids, glue, gelatins, salts of ether carboxylic acids or ether sulfonic acids of starches or celluloses, or salts of acidic sulfuric acid esters of celluloses or starches. Water-soluble, acid group-containing polyamides are also suitable for this purpose. Moreover, soluble starch preparations and others can be used as the above-mentioned starch products, e.g., degraded starches, aldehyde starches etc. Polyvinyl pyrrolidone can also be used. Preference, however, is given to the use of cellulose ethers such as carboxymethyl cel lulose (Na salt), methyl cellulose, hydroxyalkyl celluloses and mixed ethers such as methyl hy- droxyethyl cellulose, methyl hydroxypropyl cellulose, methyl carboxymethyl cellulose and mixtures thereof, as well as polyvinyl pyrrolidone, which can be added, for example, in amounts of 0.1 to 5 wt. %, based on the composition. OPTICAL BRIGHTENERS AND UV ADSORBERS

[00129] The compositions may comprise e.g., derivatives of diaminostilbene disulfonic acid or alkali metal salts thereof as the optical brighteners. Suitable optical brighteners are, for example, salts of 4, 4'-bis-(2-anilino-4-morpholino-l, 3, 5-triazinyl-6-amino)stilbene-2,2'-di- sul fonic acid or compounds of similar structure which contain a diethanolamino group, a methyl- amino group, an anilino group or a 2-methoxyethylamino group instead of the morpholino group. Brighteners of the substituted diphenylstyryl type may also be present, for example, the alkali metal salts of 4,4'-bis(2-sulfostyryl)diphenyl, 4,4'-bis(4-chloro-3-sulfostyryl)diphenyl or 4-(4-chlorostyryl)-4'-(2-sulfostyryl)diphenyl. Mixtures of the mentioned brighteners may also be used.

[00130] In addition, UV absorbers may also be added. These are compounds with distinct ab sorption abilities for ultra violet radiation, which contribute as UV stabilizers as well as to im prove the light stability of colorants and pigments both for textile fibers as well as for the skin of the wearer of textile products by protecting against the UV radiation that penetrates the fabric. In general, the efficient radiationless deactivating compounds are derivatives of ben- zophenone, substituted with hydroxyl and/or alkoxy groups, mostly in position(s) 2 and/or 4. Also suitable are substituted benzotriazoles, additionally acrylates that are phenyl-substituted in position 3 (cinnamic acid derivatives), optionally with cyano groups in position 2, salicylates, organic Ni complexes, as well as natural substances such as umbelliferone and the endoge nous urocanic acid. In a preferred embodiment, the UV absorbers absorb UV-A and UV-B ra diation as well as possible UV-C radiation and re-emit light with blue wavelengths, such that they additionally have an optical brightening effect. Preferred UV absorbers encompass tria- zine derivatives, e.g., hydroxyaryl-l,3,5-triazine, sulfonated 1,3,5-triazine, o-hydroxyphenyl- benzotriazole and 2-aryl-2H-benzotriazole as well as bis(anilinotriazinyl-amino)stilbene disul fonic acid and their derivatives. Ultra violet absorbing pigments like titanium dioxide can also be used as UV absorbers.

THICKENERS

[00131] The compositions can also comprise common thickeners and anti-deposition compo sitions as well as viscosity regulators such as polyacrylates, polycarboxylic acids, polysaccha rides and their derivatives, polyurethanes, polyvinyl pyrrolidones, castor oil derivatives, poly amine derivatives such as quaternized and/or ethoxylated hexamethylenediamines as well as any mixtures thereof. Preferred compositions have a viscosity below 10,000 mPa*s, measured with a Brookfield viscosimeter at a temperature of 20°C and a shear rate of 50 min T

PERFUMES AND COLORANTS

[00132] The compositions can comprise further typical detergent and cleansing composition ingredients such as perfumes and/or colorants, wherein such colorants are preferred that leave no or negligible coloration on the fabrics being washed. Preferred amounts of the total ity of the added colorants are below 1 wt. %, preferably below 0.1 wt. %, based on the com position. The compositions can also comprise white pigments such as e.g., Ti0 ₂ .

FOOD COMPOSITIONS

[00133] Another embodiment of the present invention covers a food composition comprising a working amount of at least one acetophenone derivative or its mixtures with additional pre servatives and/or antimicrobial agents, which might be present in amounts of from about 0.01 to about 10, preferably about 0.05 to about 5 and more preferably about 0.1 to about 1 % b.w. - calculated on the total composition.

[00134] Food compositions according to the invention are any preparations or compositions which are suitable for consumption and are used for nutrition or enjoyment purposes, and are generally products which are intended to be introduced into the human or animal oral cavity, to remain there for a certain time and then either be eaten (e.g. ready-to-eat foodstuffs or feeds, see also herein below) or removed from the oral cavity again (e.g. chewing gums). Such products include any substances or products which in the processed, partially processed or unprocessed state are to be ingested by humans or animals. They also include substances which are added to orally consumable products during their manufacture, preparation or treatment and which are intended to be introduced into the human or animal oral cavity.

[00135] The food compositions according to the invention also include substances which in the unchanged, treated or prepared state are to be swallowed by a human or animal and then digested; in this respect, the orally consumable products according to the invention also in clude casings, coatings or other encapsulations which are to be swallowed at the same time or which may be expected to be swallowed. The expression "orally consumable product" co vers ready-to-eat foodstuffs and feeds, that is to say foodstuffs or feeds that are already com plete in terms of the substances that are important for the taste. The expressions "ready-to- eat foodstuff" and "ready-to-eat feed" also include drinks as well as solid or semi-solid ready- to-eat foodstuffs or feeds. Examples which may be mentioned are frozen products, which must be thawed and heated to eating temperature before they are eaten. Products such as yoghurt or ice-cream as well as chewing gums or hard caramels are also included among the ready-to-eat foodstuffs or feeds.

[00136] Preferred food compositions according to the invention also include "semi-finished products". Within the context of the present text, a semi-finished product is to be understood as being an orally consumable product which, because of a very high content of flavourings and taste-imparting substances, is unsuitable for use as a ready-to-eat orally consumable product (in particular foodstuff or feed). Only by mixing with at least one further constituent (e.g. by reducing the concentration of the flavourings and taste-imparting substances in ques tion) and optionally further process steps (e.g. heating, freezing) is the semi-finished product converted into a ready-to-eat orally consumable product (in particular foodstuff or feed). Ex amples of semi-finished products which may be mentioned here are

[00137] Food composition according to the invention preferably comprises one or more prep arations for nutrition or enjoyment purposes. These include in particular (reduced-calorie) baked goods (e.g. bread, dry biscuits, cakes, other baked articles), confectionery (e.g. choco lates, chocolate bars, other products in bar form, fruit gums, dragees, hard and soft caramels, chewing gum), non-alcoholic drinks (e.g. cocoa, coffee, green tea, black tea, (green, black) tea drinks enriched with (green, black) tea extracts, rooibos tea, other herbal teas, fruit-containing soft drinks, isotonic drinks, refreshing drinks, nectars, fruit and vegetable juices, fruit or vege table juice preparations), instant drinks (e.g. instant cocoa drinks, instant tea drinks, instant coffee drinks), meat products (e.g. ham, fresh sausage or raw sausage preparations, spiced or marinated fresh or salt meat products), eggs or egg products (dried egg, egg white, egg yolk), cereal products (e.g. breakfast cereals, muesli bars, precooked ready-to-eat rice products), dairy products (e.g. full-fat or reduced-fat or fat-free milk drinks, rice pudding, yoghurt, kefir, cream cheese, soft cheese, hard cheese, dried milk powder, whey, butter, buttermilk, partially or completely hydrolysed milk-protein-containing products), products made from soy protein or other soybean fractions (e.g. soy milk and products produced therefrom, drinks containing isolated or enzymatically treated soy protein, drinks containing soy flour, preparations con taining soy lecithin, fermented products such as tofu or tempeh or products produced there from and mixtures with fruit preparations and optionally flavours), fruit preparations (e.g. jams, sorbets, fruit sauces, fruit fillings), vegetable preparations (e.g. ketchup, sauces, dried vegetables, frozen vegetables, precooked vegetables, boiled-down vegetables), snacks (e.g. baked or fried potato crisps or potato dough products, maize- or groundnut-based extru- dates), fat- and oil-based products or emulsions thereof (e.g. mayonnaise, remoulade, dress ings, in each case full-fat or reduced-fat), other ready-made dishes and soups (e.g. dried soups, instant soups, precooked soups), spices, spice mixtures and in particular seasonings which are used, for example, in the snacks field, sweetener preparations, tablets or sachets, other preparations for sweetening or whitening drinks or other foods. The preparations within the scope of the invention can also be used in the form of semi-finished products for the pro duction of further preparations for nutrition or enjoyment purposes. The preparations within the scope of the invention can also be in the form of capsules, tablets (uncoated and coated tablets, e.g. enteric coatings), dragees, granules, pellets, solids mixtures, dispersions in liquid phases, in the form of emulsions, in the form of powders, in the form of solutions, in the form of pastes, or in the form of other preparations which can be swallowed or chewed, and in the form of food supplements.

[00138] The preparations can also be in the form of capsules, tablets (uncoated and coated tablets, e.g. enteric coatings), dragees, granules, pellets, solids mixtures, dispersions in liquid phases, in the form of emulsions, in the form of powders, in the form of solutions, in the form of pastes, or in the form of other preparations which can be swallowed or chewed, for exam ple in the form of food supplements.

[00139] The semi-finished products are generally used for the production of ready-to-use or ready-to-eat preparations for nutrition or enjoyment purposes.

[00140] Further constituents of a ready-to-eat preparation or semi-finished product for nutri tion or enjoyment purposes can be conventional base substances, auxiliary substances and additives for foods or enjoyment foods, for example water, mixtures of fresh or processed, vegetable or animal base or raw substances (e.g. raw, roast, dried, fermented, smoked and/or boiled meat, bone, cartilage, fish, vegetables, herbs, nuts, vegetable juices, vegetable pastes or mixtures thereof), digestible or non-digestible carbohydrates (e.g. sucrose, maltose, fruc tose, glucose, dextrins, amylose, amylopectin, inulin, xylans, cellulose, tagatose), sugar alco hols (e.g. sorbitol, erythritol), natural or hardened fats (e.g. tallow, lard, palm fat, cocoa fat, hardened vegetable fat), oils (e.g. sunflower oil, groundnut oil, maize germ oil, olive oil, fish oil, soya oil, sesame oil), fatty acids or their salts (e.g. potassium stearate), proteinogenic or non-proteinogenic amino acids and related compounds (e.g. g-aminobutyric acid, taurine), peptides (e.g. glutathione), natural or processed proteins (e.g. gelatin), enzymes (e.g. pepti dases), nucleic acids, nucleotides, taste correctors for unpleasant taste impressions, further taste modulators for further, generally not unpleasant taste impressions, other taste-modu lating substances (e.g. inositol phosphate, nucleotides such as guanosine monophosphate, adenosine monophosphate or other substances such as sodium glutamate or 2-phenoxypro- pionic acid), emulsifiers (e.g. lecithins, diacylglycerols, gum arabic), stabilisers (e.g. carragee nan, alginate), preservatives (e.g. benzoic acid and its salts, sorbic acid and its salts), antioxi dants (e.g. tocopherol, ascorbic acid), chelators (e.g. citric acid), organic or inorganic acidifying agents (e.g. acetic acid, phosphoric acid), additional bitter substances (e.g. quinine, caffeine, limonene, amarogentine, humulone, lupulone, catechols, tannins), substances that prevent enzymatic browning (e.g. sulfite, ascorbic acid), ethereal oils, plant extracts, natural or syn thetic colourings or colouring pigments (e.g. carotinoids, flavonoids, anthocyans, chlorophyll and derivatives thereof), spices, trigeminally active substances or plant extracts containing such trigeminally active substances, synthetic, natural or nature-identical flavourings or odor ants as well as odour correctors. [00141] Food compositions according to the invention, for example those in the form of prep arations or semi-finished products, preferably comprise a flavour composition in orderto com plete and refine the taste and/or odour. A preparation can comprise as constituents a solid carrier and a flavour composition. Suitable flavour compositions comprise, for example, syn thetic, natural or nature-identical flavourings, odorants and taste-imparting substances, reac tion flavourings, smoke flavourings or other flavour-giving preparations (e.g. protein (partial) hydrolysates, preferably protein (partial) hydrolysates having a high arginine content, barbe cue flavourings, plant extracts, spices, spice preparations, vegetables and/or vegetable prep arations) as well as suitable auxiliary substances and carriers. Particularly suitable here are the flavour compositions or constituents thereof which produce a roasted, meaty (in particular chicken, fish, seafood, beef, pork, lamb, mutton, goat), vegetable-like (in particular tomato, onion, garlic, celery, leek, mushroom, aubergine, seaweed), spicy (in particular black and white pepper, cardamom, nutmeg, pimento, mustard and mustard products), fried, yeast-like, boiled, fatty, salty and/or pungent flavour impression and accordingly can enhance the spicy impression. The flavour compositions generally comprise more than one of the mentioned ingredients.

[00142] The food compositions of the present invention are preferably selected from the group comprising

• confectionery, preferably reduced-calorie or calorie-free confectionery, preferably se lected from the group comprising muesli bar products, fruit gums, dragees, hard cara mels and chewing gum,

• non-alcoholic drinks, preferably selected from the group comprising green tea, black tea, (green, black) tea drinks enriched with (green, black) tea extracts, rooibos tea, other herbal teas, fruit-containing low-sugar or sugar-free soft drinks, isotonic drinks, nectars, fruit and vegetable juices, fruit and vegetable juice preparations,

• instant drinks, preferably selected from the group comprising instant (green, black, rooi bos, herbal) tea drinks,

• cereal products, preferably selected from the group comprising low-sugar and sugar- free breakfast cereals and muesli bars,

• dairy products, preferably selected from the group comprising reduced-fat and fat-free milk drinks, yoghurt, kefir, whey, buttermilk and ice-cream,

• products made from soy protein or other soybean fractions, preferably selected from the group comprising soy milk, products produced from soy milk, drinks containing iso lated or enzymatically treated soy protein, drinks containing soy flour, preparations con taining soy lecithin, products produced from preparations containing soy lecithin and mixtures with fruit preparations and optionally flavours,

• sweetener preparations, tablets and sachets, • sugar-free dragees,

• ice-cream, with or without milk-based constituents, preferably sugar-free.

AROMA OR FLAVOURING COMPOUNDS

[00145] Aroma compounds and flavouring agents (component d) are well known in the art can be added to the flavour compositions of the invention. These flavouring agents can be chosen from synthetic flavouring liquid and/or oils derived from plants leaves, flowers, fruits and so forth, and combinations thereof. Representative flavouring liquids include: artificial, natural or synthetic fruit flavours such as eucalyptus, lemon, orange, banana, grape, lime, apricot and grapefruit oils and fruit essences including apple, strawberry, cherry, orange, pineapple and so forth; bean and nut derived flavours such as coffee, cocoa, cola, peanut, almond and so forth; and root derived flavours such as licorice or ginger.

[00146] The flavouring agent is preferably selected from the group consisting of essential oils and extracts, tinctures and balsams, such as, for example, anisole, basil oil, bergamot oil, bitter almond oil, camphor oil, citronella oil, lemon oil; Eucalyptus citriodora oil, eucalyptus oil, fennel oil, grapefruit oil, camomile oil, spearmint oil, caraway oil, lime oil, mandarin oil, nutmeg oil (in particular nutmeg blossom oil = maces oil, mace oil), myrrh oil, clove oil, clove blossom oil, orange oil, oregano oil, parsley (seed) oil, peppermint oil, rosemary oil, sage oil (clary sage, Dalmatian or Spanish sage oil), star aniseed oil, thyme oil, vanilla extract, juniper oil (in particular juniper berry oil), wintergreen oil, cinnamon leaf oil; cinnamon bark oil, and fractions thereof, or constituents isolated therefrom.

[00147] It is of particular advantage if the flavoured composition according to the invention comprises at least one flavouring agent, preferably two, three, four, five, six, seven, eight or more flavouring agents chosen from the following group: menthol (preferably l-menthol and/or racemic menthol), anethole, anisole, anisaldehyde, anisyl alcohol, (racemic) neomen thol, eucalyptol (1,8-cineol), menthone (preferably L-menthone), isomenthone (preferably D- isomenthone), isopulegol, menthyl acetate (preferably L-menthyl acetate), menthyl propio nate, carvone (preferably (-)-carvone, optionally as a constituent of a spearmint oil), methyl salicylate (optionally as a constituent of a wintergreen oil), eugenol acetate, isoeugenol me thyl ether, beta-homocyclocitral, eugenol, isobutyraldehyde, 3-octanol, dimethyl sulfide, hex- anol, hexanal, trans-2-hexenal, cis-3-hexenol, 4-terpineol, piperitone, linalool, 8-ocimenyl ac etate, isoamyl alcohol, isovaleraldehyde, alpha-pinene, beta-pinene, limonene (preferably D- limonene, optionally as a constituent of an essential oil), piperitone, trans-sabinene hydrate, menthofuran, caryophyllene, germacrene D, cinnamaldehyde, mint lactone, thymol, gamma- octalactone, gamma-nonalactone, gamma-decalactone, (l,3E,5Z)-undecatriene, 2-butanone, ethyl formate, 3-octyl acetate, isoamyl isovalerate, cis- and trans-carvyl acetate, p-cymol, damascenone, damascone, cis-rose oxide, trans-rose oxide, fenchol, acetaldehyde diethyl ac- etal, 1-ethoxyethyl acetate, cis-4-heptenal, cis-jasmone, methyl dihydrojasmonate, 2'-hydrox- ypropiophenone, menthyl methyl ether, myrtenyl acetate, 2-phenylethyl alcohol, 2-phe- nylethyl isobutyrate, 2-phenylethyl isovalerate, geraniol, nerol and viridiflorol.

[00148] In particular preferred aroma or flavouring compounds encompass menthol, cineol, eugenol, thymol, cinnamic aldehyde, peppermint oil, spearmint oil, eucalyptus oil, thyme oil, cinnamon oil, clove oil, spruce needle oil, fennel oil, sage oil, aniseed oil, star anise oil, cham omile oil, and caraway oil, and their mixtures.

SWEETENERS

[00149] The term "sweeteners" here denotes substances having a relative sweetening power of at least 25, based on the sweetening power of sucrose (which accordingly has a sweetening power of 1). Sweeteners to be used in an orally consumable product (in particular foodstuff, feed or medicament) according to the invention (a) are preferably non-cariogenic and/or have an energy content of not more than 5 kcal per gram of the orally consumable product.

[00150] Advantageous sweeteners in a preferred food composition according to the inven tion are selected from the following groups:

[00151] Naturally occurring sweeteners, preferably selected from the group comprising

• miraculin, monellin, mabinlin, thaumatin, curculin, brazzein, pentaidin, D-phenylala- nine, D-tryptophan, and extracts or fractions obtained from natural sources, comprising those amino acids and/or proteins, and the physiologically acceptable salts of those amino acids and/or proteins, in particular the sodium, potassium, calcium or ammonium salts;

• neohesperidin dihydrochalcone, naringin dihydrochalcone, stevioside, steviolbioside, rebaudiosides, in particular rebaudioside A, rebaudioside B, rebaudioside C, rebaudi- oside D, rebaudioside E, rebaudioside F, rebaudioside G, rebaudioside H, dulcosides and rubusoside, suavioside A, suavioside B, suavioside G, suavioside H, suavioside I, suavio- side J, baiyunoside 1, baiyunoside 2, phlomisoside 1, phlomisoside 2, phlomisoside 3 and phlomisoside 4, abrusoside A, abrusoside B, abrusoside C, abrusoside D, cyclocaryoside A and cyclocaryoside I, osladin, polypodoside A, strogin 1, strogin 2, strogin 4, selligueain A, dihydroquercetin 3-acetate, perillartin, telosmoside A ₁₅ , periandrin l-V, pterocaryo- sides, cyclocaryosides, mukuroziocides, trans-anethole, trans-cinnamaldehyde, bryo- sides, bryonosides, bryonodulcosides, carnosiflosides, scandenosides, gypenosides, tri- lobatin, phloridzin, dihydroflavanols, hematoxylin, cyanin, chlorogenic acid, albiziasapo- nin, telosmosides, gaudichaudioside, mogrosides, mogroside V, hernandulcins, monatin, phyllodulcin, glycyrrhetinic acid and derivatives thereof, in particular glycosides thereof such as glycyrrhizine, and the physiologically acceptable salts of those compounds, in particular the sodium, potassium, calcium or ammonium salts; • extracts or concentrated fractions of the extracts, selected from the group comprising thaumatococcus extracts (katamfe plant), extracts from Stevia ssp. (in particular Stevia rebaudiana), swingle extracts (Momordica or Siratia grosvenorii, Luo-Han-Guo), extracts from Glycerrhyzia ssp. (in particular Glycerrhyzia glabra), extracts from Rubus ssp. (in particular Rubus suavissimus), citrus extracts and extracts from Lippia dulcis;

[00145] Synthetic sweet-tasting substances, preferably selected from the group comprising magap, sodium cyclamate or other physiologically acceptable salts of cyclamic acid, acesul- fame K or other physiologically acceptable salts of acesulfame, neohesperidin dihydrochal- cone, naringin dihydrochalcone, saccharin, saccharin sodium salt, aspartame, superaspar tame, neotame, alitame, advantame, perillartin, sucralose, lugduname, carrelame, sucro- nonate and sucrooctate.

THICKENERS

[00145] Advantageous thickeners in a preferred orally consumable product (in particular foodstuff, feed or medicament) according to the invention a re selected from the group com prising: crosslinked polyacrylic acids and derivatives thereof, polysaccharides and derivatives thereof, such as xanthan gum, agar-agar, alginates or tyloses, cellulose derivatives, for exam ple carboxymethylcellulose or hydroxycarboxymethylcellulose, fatty alcohols, monoglycerides and fatty acids, polyvinyl alcohol and polyvinylpyrrolidone.

[00146] Preference is given according to the invention to an orally consumable product (in particular foodstuff or feed) which comprises milk thickened with lactic acid bacteria and/or cream thickened with lactic acid bacteria and which preferably is selected from the group comprising yoghurt, kefir and quark.

[00147] A food composition according to the invention comprising milk thickened with lactic acid bacteria and/or cream thickened with lactic acid bacteria is advantageously an orally con sumable product which comprises a probiotic, wherein the probiotic is preferably selected from the group comprising Bifidobacterium animalis subsp. lactis BB-12, Bifidobacterium ani- malis subsp. lactis DN-173 010, Bifidobacterium animalis subsp. lactis HN019, Lactobacillus acidophilus LA5, Lactobacillus acidophilus NCFM, Lactobacillus johnsonii Lai, Lactobacillus ca- sei immunitass/defensis, Lactobacillus casei Shirota (DSM 20312), Lactobacillus casei CRL431, Lactobacillus reuteri (ATCC 55730) and Lactobacillus rhamnosus (ATCC 53013). ADDITIVES FOR CHEWING GUMS

[00148] Particular preference is given to an orally consumable product (in particular food stuff, feed or medicament) according to the invention that is a chewing gum and comprises a chewing-gum base. The chewing-gum base is preferably selected from the group comprising chewing-gum or bubble-gum bases. The latter are softer, so that gum bubbles can also be formed therewith. Preferred chewing-gum bases according to the invention include, in addi tion to the natural resins or the natural latex chicle that are traditionally used, elastomers such as polyvinyl acetate (PVA), polyethylene, (low or medium molecular weight) polyisobutene (PIB), polybutadiene, isobutene-isoprene copolymers (butyl rubber), polyvinyethyl ether (PVE), polyvinylbutyl ether, copolymers of vinyl esters and vinyl ethers, styrene-butadiene co polymers (styrene-butadiene rubber, SBR) or vinyl elastomers, for example based on vinyl ac etate/vinyl laurate, vinyl acetate/vinyl stearate or ethylene/vinyl acetate, as well as mixtures of the mentioned elastomers, as described, for example, in EP 0 242 325, US 4,518,615, US 5,093,136, US 5,266,336, US 5,601,858 or US 6,986,709. In addition, chewing-gum bases that are preferably to be used according to the invention preferably comprise further constituents such as, for example, (mineral) fillers, plasticisers, emulsifiers, antioxidants, waxes, fats or fatty oils, such as, for example, hardened (hydrogenated) vegetable or animal fats, mono-, di- or tri-glycerides. Suitable (mineral) fillers are, for example, calcium carbonate, titanium diox ide, silicon dioxide, talcum, aluminium oxide, dicalcium phosphate, tricalcium phosphate, magnesium hydroxide and mixtures thereof. Suitable plasticisers, or agents for preventing ad hesion (detackifiers), are, for example, lanolin, stearic acid, sodium stearate, ethyl acetate, diacetin (glycerol diacetate), triacetin (glycerol triacetate), triethyl citrate. Suitable waxes are, for example, paraffin waxes, candelilla wax, carnauba wax, microcrystalline waxes and poly ethylene waxes. Suitable emulsifiers are, for example, phosphatides such as lecithin, mono- and di-glycerides of fatty acids, for example glycerol monostearate.

[00149] Chewing gums according to the invention (in particular as disclosed above) preferably comprise constituents such as sugars of different types, sugar substitutes, other sweet-tasting substances, sugar alcohols (in particular sorbitol, xylitol, mannitol), ingredients having a cool ing effect, taste correctors for unpleasant taste impressions, further taste-modulating sub stances (e.g. inositol phosphate, nucleotides such as guanosine monophosphate, adenosine monophosphate or other substances such as sodium glutamate or 2-phenoxypropionic acid), humectants, thickeners, emulsifiers, stabilisers, odour correctors and flavours (e.g. eucalyp tus-menthol, cherry, strawberry, grapefruit, vanilla, banana, citrus, peach, blackcurrant, trop ical fruits, ginger, coffee, cinnamon, combinations (of the mentioned flavours) with mint fla vours as well as spearmint and peppermint on their own). The combination inter alia of the flavours with further substances that have cooling, warming and/or mouth-watering proper ties is of particular interest.

METHODS FOR PRESERVATION AND FIGHTING BODY ODOR [00150] The acetophenone derivatives and the respective mixtures according to the invention display their synergistically intensified antimicrobial action against a large number of Gram positive bacteria, Gram-negative bacteria, moulds and yeasts, which in particular renders pos sible preservation and antimicrobial treatment of a large number of cosmetic formulations. A particularly good action exists against Gram-positive bacteria, such as Staphylococcus aureus, Staphylococcus epidermidis, Corynebacterium xerosis, and Propionibacterium acnes, against Gram-negative bacteria, such as Escherichia coli and Pseudomonas aeruginosa, against yeasts, such as Candida albicans, Malassezia furfur and globosa, and precisely - as already mentioned - against fungi, such as mould species of the genus Aspergillus and others. The very good ac tivity of the mixtures according to the invention against moulds of the genus Aspergillus, a fungal group, which can be combated only with great difficulty, is to be regarded as particu larly advantageous here.

[00151] Therefore, another object of the present invention relates to a method for preserving a personal care composition, a detergent composition or a food composition by adding a working amount of at least one acetophenone derivative or its mixture with a second preserv ative or an antimicrobial agent.

[00152] Another object of the present invention refers to a method for fighting micro-organ isms by adding a working amount of at least one acetophenone derivative or its mixture with a second preservative or an antimicrobial agent to a personal care, detergent or food compo sition.

[00153] The invention covers also the use of at least one acetophenone derivative or its mix ture with a second preservative or an antimicrobial agent as a preservative, in particular for personal care, detergent or food compositions, preferably in amounts of from about 0.01 to about 10, preferably about 0.05 to about 5 and more preferably about 0.1 to about 1 % b.w.

[00154] Another object of the present invention refers to a method for fighting micro-organ isms by adding a working amount of at least one acetophenone derivative or its mixture with a second preservative or an antimicrobial agent.

[00155] The acetophenone derivatives and their mixtures are particularly useful against mi croorganisms which cause body odour, acne and/or mycoses. Advantageously, the preserva tives or preservative mixtures are applied to human skin at concentrations of 0.01 to about 10, preferably about 0.05 to about 5 and more preferably about 0.1 to about 1 % b.w. in each case based on the total weight of the cosmetic or pharmaceutical product which comprises the mixture. The synergistically active mixtures can be employed here (a) prophylactically or (b) as required. The concentration of the amount of active compound to be applied e.g. daily varies and depends on the physiological state of the subject and individual-specific parame ters, such as age or body weight. The synergistically active mixtures according to the invention can be employed either by themselves or in combination with further antimicrobically active substances. [00156] Another object of the present invention therefore covers a method for treating un pleasant body odour, in particular underarm and foot odour by topical administration a work ing amount of at least one acetophenone derivative or its mixture with a second preservative or an antimicrobial agent to the skin. Finally, the invention refers to the use of at least one acetophenone derivative or its mixture with a second preservative or an antimicrobial as a deodorant.

[00157] It is understood that the explanations and preferred embodiments outlined above with respect to the acetophenone derivatives and their mixtures mutatis-mutandis apply also for the methods and uses as claimed, thus no additional repetition is necessary.

EXAMPLES

EXAMPLE 1

[00158] Synergistic activity of 4-hydroxyacetophenone in combination with various second ary antimicrobial agents against the microorganism A. brasiliensis was determined. To calcu late the synergism between compounds of formula (I) and other antimicrobial actives, the Kull equation ^{1 2} was used

( I ) SI — (Cmixture X PA) / CA + (Cmixture X PB) / CB

where

SI is the Synergy Index according to Kull ^{1)< 2)}

CA is the cell count for substance A

CB is the cell count for substance B

Cmi _xtu r _e is the cell count for the mixture of substances A and B

PA is the proportion of the substance A in the mixture

PB is the proportion of the substance B in the mixture.

[00159] Antimicrobil activity was evaluated by determining the Miniumum Inhibitory Concen tration (MIC) representing the lowest concentration of a chemical which prevents visi ble growth of a bacterium.

¹ Kull, F.C., Eismann, P.C., Sylvestrowicz, H.D., and R.L. Mayer (1961). Mixtures of Quaternary Ammonium Com pounds and Long-chain Fatty Acids as Antifungal Agents. Applied Microbiology 9, 538 - 541.

² Steinberg, D.C. (2000). Measuring Synergy. Cosmetics & Toiletries 115 (11), 59-62. [00160] The MIC values were determined by preparing solutions of the chemical in vitro at increasing concentrations, incubating the solutions with the separate batches of cultured bac teria, and measuring the results using agar dilution or broth microdilution. Results have been graded into susceptible (often called sensitive), intermediate, or resistant to a particular anti- biotic by using a cutoff point. Cut off points are agreed upon values, published in guidelines of a reference body, such as the U.S. Clinical and Laboratory Standards Institute (CLSI), the British Society for Antimicrobial Chemotherapy (BSAC) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST).

*) MIC values for the actives taken alone

*) MIC values for the respective mixtures of the actives when combined with 4-hydroxyacetophenone in the respective ratio by weight (4-HAP:A) and the resulting synergy index according to Kull. Values <1 stand for syn- ergistic activity compared to the actives taken alone.

[00161] The Synergy Index SI for the combination of 4-hydroxyacetophenone and the sec ondary actives indicate a very strong synergism between these two compounds.

FORMULATION EXAMPLES

[00145] The present invention is further illustrated by the following examples. If not indicated otherwise a reference to a "substance of formula (I)" relates to 4-hydroxyacetophenone (com pound of formula (lc)). However, the "substance of formula (I)" can be replaced by any other compound of formula (I). In particular 4-hydroxyacetophenone can be replaced by 2-hydrox- yacetophenone (compound of formula (la)) or 3-hydroxyacetophenone (compound of for mula (lb)).

Table IA

Perfume oil PI (Amounts in % b.w.)

Table IB

Perfume oil P2 (Amounts in % b.w.)

Table 1C

Perfume oil P3 (Amounts in % b.w.)

Table ID

Perfume oil P4 with white blossom smell (Amounts in % b.w.)

The perfume oils PI. P2. P3. and P4 from the above examples were worked separately in each case into the here presented form ulations. Table II

Liquid soap transparent (Amounts in % b.w.)

Table III

Syndet soap, liquid (Amounts in % b.w.)

Table IV

Cosmetic lotion for body wash (Amounts in % b.w.) Table V

Cosmetic lotion for body wash with Triclosan (Amounts in % b.w.)

Table VI

Intimate wash (Amounts in % b.w.)

Table VII

Liquid soap (Amounts in % b.w.)

Table VIII

Shampoo (Amounts in % b.w.)

Table IX

2-in-l Shampoo (Amounts in % b.w.)

Table X

Anti-dandruff Shampoo (Amounts in % b.w.) Table XI

Hair conditioner with Crinipan. rinse-off (Amounts in % b.w.)

Table XII

Sprayable hair conditioner with zinc pyrithrione. leave-on (Amounts in % b.w.)

Table XIII

Hair conditioner with UV protection (Amounts in % b.w.)

Table XIV

Shower gel (Amounts in % b.w.)

Table XV

Shaving foam (Amounts in % b.w.)

Table XVI

Depilatory cream (Amounts in % b.w.) Table XVII

After Shave Tonic (Amounts in % b.w.)

Table XVIII

Deodorant formulation in the form of a roll-on gel (Amounts in % b.w.) Table XIX

Clear deo anti-perspirant roll-on (Amounts in % b.w.)

Table XX

Deodorant stick (Amounts in % b.w.)

Table XXI

Zirconium suspensoid antiperspirant stick (Amounts in % b.w.)

Table XXII

Deodorant pump spray with SymClariol (Amounts in % b.w.) Table XXIII

Antiperspirant formulations (Amounts in % b.w.)

Table XXIV

Deodorant spray with Triclosan (Amounts in % b.w.) Table XXV

O/W lotion (Amounts in % b.w.)

Table XXVI

Body lotion (Amounts in % b.w.) Table XXVII

Cream (Amounts in % b.w.)

Table XXVIII

Cream (Amounts in % b.w.)

Table XXIX

Hand and body cream (Amounts in % b.w.) Table XXX

Face cream (Amounts in % b.w.)

Table XXXI

Moisturizing body care cream (Amounts in % b.w.)

Table XXXII

Anti-wrinkle cream (Amounts in % b.w.)

Table XXXIII

Functional skin oil for disinfection (Amounts in % b.w.)

Table XXXIV

Septic wound cream (Amounts in % b.w.)

Table XXXV

Moisturizing and disinfecting face mask (Amounts in % b.w.) Table XXXVI

Sprayable disinfecting gel (Amounts in % b.w.)

Table XXXVII

Mineral wash and cleaning gel (Amounts in % b.w.)

Table XXXVIII

Anti-acne wash (Amounts in % b.w.)

Table XXXIX

Cosmetic sun protection composition (Amounts in % b.w.)

Table XXXX

Sun protection spray (Amounts in % b.w.)

Table XXXXI

Sunscreen spray 0/W. SPE 15-20 (Amounts in % b.w.)

Table XXXXII

Sun protection soft cream (W/O). SPF 40 (Amounts in % b.w.)

Table XXXXIII

Sun protection milk (W/O) (Amounts in % b.w.) Table XXXXIV

After sun gel (Amounts in % b.w.)

Table XXXXV

After sun lotion (Amounts in % b.w.)

Table XXXXVI

Hair styling gel (Amounts in % b.w.)

Table XXXXVII

Silicone emulsion (Amounts in % b.w.)

Table XXXXVIII

Microemulsion gel (Amounts in % b.w.) Table XXXXIX

Air freshener in gel form (Amounts in % b.w.)

Table L

Cleaner. APC liquid, alkaline pH 8-10 (Amounts in % b.w.)

Table LI

Fabric softener (Amounts in % b.w.) Table Lll

Liquid detergent (Amounts in % b.w.)

Table Llll

Liquid detergent concentrate (Amounts in % b.w.) Table LIV

Toilet cleaner (Amounts in % b.w.)

Table LV

Dish washing concentrate (Amounts in % b.w.)

Table LVI

Dish washing concentrate (Amounts in % b.w.) Table LVII

Solution for wet wipes (Amounts in % b.w.)

Wet cleansing wipes

Preparation of a composition or mixture for neutralising unpleasant odours and / or desinfect- ing with wet cleansing wipes: The following components are mixed to form a composition or mixture: 30 parts by weight of dipropylene glycol. 25 parts by weight of Substance of formula (I). 15 parts by weight of isopropyl myristate. 15 parts by weight of triethyl citrate and 15 parts by weight of benzyl benzoate. Using an emulsifier (Dracorin GOC). a 0.05 % aqueous solution is produced from this composition and is used to manufacture wet cleansing wipes.

Table LVIIIA Peppermint Flavour PF1 (Amounts in % b.w.)

Table LVIIIB

Wintergreen flavor PF2 (Amounts in % b.w.)

Table LVIIIC

Isoamylacetate type flavor PF3 (Amounts in % b.w.)

Table LVIIID

Cinnamon type cool flavor PF4 (Amounts in % b.w.)

Table LIX

Toothpaste (Amounts in % b.w.)

Table LX

Toothpaste with zinc citrate (Amounts in % b.w.)

Table LXI

Mouth rinse (Amounts in % b.w.)

Table LXII

Gel dental cream (Amounts in % b.w.)

Table LXIII

Dental cream against plaque (Amounts in % b.w.) Table LXIV

Dental cream for sensitive teeth (Amounts in % b.w.)

Table LXV

Tooth cream and mouthwash 2-in-l product (Amounts in % b.w.)

Table LXVI

Ready-to-use mouthwash with fluoride (Amounts in % b.w.)

Table LXVII

Sugar-free chewing-gum (Amounts in % b.w.)